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Introduction: Malaria is a deadly infectious disease that affects millions of people 
around the world. This vector-borne tropical disease is caused by parasites that belong to 
the Plasmodium genus and is transmitted through the bite of an infected female 
Anopheles mosquito. Tools such as long-lasting insecticide nets (LLINs) and attractive 
toxic sugar baits (ATSBs) have been shown to work well in delivering insecticides to 
mosquitoes, but due to the spread of insecticide resistance throughout sub-Saharan Africa 
and Southeast Asia, there has been much interest in finding alternative chemical 
compounds against Anopheles mosquitoes. Compounds, such as methoxyfenozide 
(MET), have been shown to have insecticidal effects against Anopheles gambiae females. 
MET alongside another insecticide, hydramethylnon (HYD), have been shown to have 
antimalarial properties against mosquito-stage Plasmodium falciparum parasites; HYD’s 
insecticidal effects on A. gambiae is unknown. Atovaquone (ATQ), a known antimalarial 
drug for humans, has been observed to have antimalarial properties against mosquito-
stage P. falciparum. The primary focus of my study is to assess the potential of the three 
compounds when used in tarsal contact assays (MET) or sugar feeding assays (ATQ, 
HYD, and MET).  
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Methods: A. gambiae females were exposed to ATQ, HYD, or MET through sugar 
feeding assays, and MET through tarsal contact assays to assess the effect of these 
compounds on mosquito survival, P. falciparum infection, or mosquito egg development. 
Effects on P. falciparum infection were assessed through oocyst intensity, the prevalence 
of infection, the oocyst size, and the number of sporozoites present in the salivary glands.  
Results: Through sugar feeding, ATQ induced a significant reduction in P. falciparum 
prevalence of infection when A. gambiae were exposed to the treated sugars before an 
infectious blood meal. ATQ had also significant effects on P. falciparum oocyst size and 
number of sporozoites when A. gambiae were continuously exposed to the treated sugars 
after an infectious blood meal. There was a dose-dependent survival effect caused by 
HYD on A. gambiae females through sugar feeding, and also a significant effect of HYD-
treated sugar feeding on the prevalence of P. falciparum infections. MET had little effect 
through tarsal contact on infection and egg development but showed significant effects on 
egg development through sugar feeding.  
Conclusion: This study identified important compounds that could be used in ATSBs and 
LLINs. In particular, ATQ had antimalarial effects when infected mosquitoes were 
exposed to ATQ-treated sugar meals, and HYD-treated sugar meals had insecticidal 
effects against A. gambiae mosquitoes, with promising implications for the future of 
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Malaria is a deadly infectious disease that affects millions of people around the 
world. This vector-borne tropical disease is caused by parasites that belong to the 
Plasmodium genus and is transmitted through the bite of an infected female Anopheles 
mosquito (WHO, 2019b). Indicators of malaria can be flu-like symptoms, such as high 
fevers and chills; however, malaria can lead to severe illnesses, such as severe anemia, 
jaundice, or cerebral malaria. Untreated, malaria can lead to death (Milner, 2018). 
According to the World Malaria Report 2019, in 2018, there were an estimated 228 
million cases worldwide, and out of these cases, there were an estimated 405,000 deaths 
(WHO, 2019b). With millions of people infected with this parasite and billions of people 
at risk of infection, malaria eradication should be a priority for health organizations, 
research institutes, and governments around the world. 
 
I. Burden of Malaria: A Public Health Concern 
Malaria is a debilitating illness that not only affects millions of people but also 
places a huge burden on the communities and countries where malaria is endemic. 
Eighty-five percent of the burden falls on nineteen countries—of which eighteen 
countries are in the sub-Saharan Africa region, with the only country outside of this 
region being India. Ninety-three percent of the malaria cases occurring in 2018 were in 
the Africa region (WHO, 2019b). In malaria-endemic countries, the disease is one of the 
factors contributing to an obstinate and complex cycle of poverty. Malaria is referred to 
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as “a tropical disease of poor countries,” as the countries still battling malaria are some of 
the poorest countries in the world (Teklehaimanot & Mejia, 2008). In fact, around 58% of 
the cases worldwide befall the poorest 20% of the world’s population (Breman et al., 
2004). While the climate and environmental characteristics of these countries are the 
main contributors to malaria transmission, those living in poverty are hit hardest due to 
the cost of preventative measures and treatment (European Alliance Against Malaria, 
2007). The insufficient healthcare infrastructures in some malaria-afflicted countries 
make eradication programs difficult to implement and patients difficult to access for 
treatment (Nájera et al., 2011). In 2018, 67% of the estimated 405,000 deaths caused by 
malaria were children under five years, a population that is most vulnerable to malaria 
infections. These cases remain largely due to the inaccessibility of health care for some 
families, where as much as 40% of febrile children in sub-Saharan Africa did not have a 
trained medical provider to treat their symptoms — to put this “40%” into perspective, 24 
million children in Sub-Saharan Africa are estimated to be infected with Plasmodium 
falciparum in 2018 (WHO, 2019b). The absence of resources to seek timely treatment, 
the inability to afford simple prevention measures, and a lack of education and 
knowledge on malaria prevention and symptoms operate to perpetuate both illness and 
poverty in these communities (Nájera et al., 2011; Teklehaimanot & Mejia, 2008). In 
fact, the WHO states that reducing malaria by 10% will increase the annual GDP of a 
country by 0.3% (WHO, 2019b). With malaria and poverty being so strongly connected, 
governments, NGOs, and researchers should invest more research and public health effort 
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and financial support to find better, more affordable, and more accessible tools and 
treatments for malaria control.  
 While at present malaria is localized in certain regions of the world, like Africa 
and Southeast Asia, a century ago the disease was found even in temperate regions such 
as North America and Europe (Ashley et al., 2018; Talapko et al., 2019). The 
establishment of the World Health Organization by the United Nations in the mid-1900s 
put greater priority on eradicating malaria and other infectious diseases worldwide. 
Eradication efforts, in the form of the WHO’s Global Malaria Eradication Program 
(GMEP), successfully eliminated malaria from or controlled malaria in several regions 
around the world, including parts of southern Europe, Singapore, Hong Kong, and parts 
of Malaysia, India, and Sri Lanka, since its establishment in 1955 until the end of the 
program in 1968 (Majori, 1999; Nájera et al., 2011). Strategy-wise, the program heavily 
relied on the use of dichloro-diphenyl-trichloroethane (DDT), a commonly used 
agricultural insecticide from the mid 1900s, and on the use of mass drug administration 
of chloroquine, an effective antimalarial treatment and prophylaxis (Meibalan & Marti, 
2017). However, heavy resistance developed against both DDT and chloroquine, leading 
to their decreased effectiveness in malaria eradication. Additionally, the GMEP used a 
“one-size-fits-all” method for malaria eradication worldwide; this approach meant that 
they were unable to adapt to the greater presence of malaria transmission in less 
developed regions nor to the increasing resistance against both insecticide and drug 
(Bleakley, 2010; WHO, 2014).  Alongside these failures of GMEP, the decreasing 
momentum, the lack of continuous eradication efforts, and the decline in funding and 
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investments in malaria eradication have all contributed to the devastating resurgence of 
malaria in several countries, many of which were close to elimination in the past. Many 
tropical countries, where the climate and environment provide the optimal grounds for 
transmission, are still struggling to end malaria in 2020 (Dhiman, 2019; Nájera et al., 
2011). Despite the decreased momentum in malaria eradication after GMEP, renewed 
interest has brought tremendous improvements and progress in the WHO goals for 
malaria eradication at the turn of the century.  
Progress has been made in several countries. In Figure 1, many countries have 
shown a significant reduction in malaria cases per year, having zero cases for 3 
consecutive years in 2018, when in 2000 they were endemic. Nonetheless, many 
countries are still afflicted by malaria, with more than one indigenous case a year as 
highlighted in red (Figure 1). The incidence rate of clinical malaria has decreased by 40% 
between 2000 and 2015 (Bhatt et al., 2015). Nonetheless, recent data shows that the 
decreased incidence rate has plateaued between 2014 and 2018 when the incidence rate 
of malaria has remained 57 cases per 1000 population at risk (WHO, 2019b). This 
suggests that current methods of intervention and treatment are no longer sufficient in 
reducing malaria burden. In 2011, a paper in Cell Press by Ranson, et al., raised 
awareness that no new insecticide classes for widespread public health application have 
been discovered in more than 30 years prior to 2011 due to a lack of research funding, a 
fact which shows the prior loss of momentum in malaria eradication efforts (Ranson et 
al., 2011). As mentioned in Nájera’s 2011 paper, Mark Boyd, a previous president of the 
American Academy of Tropical Medicine and the American Society of Tropical 
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Medicine, described malaria control as not a campaign but a long-term program that 
should be consistently maintained rather than sporadically administered (Nájera et al., 
2011). In line with Boyd’s vision of malaria control, it is important to maintain 
momentum and to continue funding or investing in resources for malaria eradication. 
  
Figure 1 The statuses of countries where malaria was endemic in 2000 are revisited in 
2018. Red = countries where malaria is still endemic in 2018; Pink = 0 cases for 2 
consecutive years in 2018; Blue = 0 cases for 3 or more consecutive years in 2018; 
Green = countries certified malaria free after 2000 (WHO, 2019b).  
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II. Transmission of Malaria: Parasite-Host Interactions 
Based on current knowledge, there are over one hundred Plasmodium species that 
can infect a variety of reptiles, birds, and mammals. However, of these hundred or more 
Plasmodium species, five have been confirmed to cause malaria in humans —P. 
falciparum, P. malariae, P. vivax, P. ovale, and P. knowlesi (Milner, 2018; Talapko et al., 
2019). Other Plasmodium species, P. cynomolgi and P. simium, both of which naturally 
infects simian primates, have been recently shown to infect humans naturally as well 
(Ashley et al., 2018; Brasil et al., 2017; Hartmeyer et al., 2019; Ta et al., 2014).  Forty 
percent of the world's population is at risk of contracting malaria from these Plasmodium 
species, and of the species listed above, P. falciparum is the deadliest, accounting for the 
majority of the cases in Africa, the Eastern Mediterranean, and the Western Pacific, 
traditionally causing the majority of malaria-related deaths (Smith & Jacobs-Lorena, 
2010; Tediosi et al., 2017; WHO, 2019b). In 2018, P. falciparum caused 99.7% of the 
estimated cases of malaria worldwide (WHO, 2019b). While P. falciparum is the most 
dangerous, the other species of Plasmodium also pose huge threats to the goal of 
eradicating malaria.  
The malaria-causing species, P. vivax, is the predominant Plasmodium species in 
the Americas and has the highest burden in Southeast Asia, where it is responsible for 
half of the cases in this region (WHO, 2019a). P. vivax is the cause of 70% or more cases 
in countries with lower malaria transmission and can also cause severe malaria and 
malaria-related deaths (Cowman et al., 2016; Shretta et al., 2017). P. vivax is known for 
causing relapsing and chronic symptoms, as the parasite is capable of remaining dormant 
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in the host’s liver for a while before the host exhibits any symptoms. Additionally, 
gametocytes of P. vivax tend to develop before the onset of symptoms, making the 
disease transmissible before its detection. These characteristics of P. vivax make it 
difficult to eliminate (Dhiman, 2019; Milner, 2018; Shretta et al., 2017). In places where 
P. falciparum and P. vivax coincide, P. falciparum is more easily managed with malaria 
control interventions than P. vivax (WHO, 2015). In fact, in countries where P. 
falciparum and P, vivax coexist, the proportion of P. vivax infections tend to increase as 
the proportion of P. falciparum infections tend to decrease, attesting to the difficulty in 
controlling P. vivax malaria (Shretta et al., 2017). Despite the more devastating and 
deadly pathogenesis of malaria when one is infected with P. falciparum, treating other 
human Plasmodium parasites is still just as important in reducing malaria transmission. 
More severe manifestations of clinical malaria in other Plasmodium parasites can be just 
as deadly, especially to vulnerable populations such as children, pregnant women, and 
immunocompromised individuals (Milner, 2018; WHO, 2015). 
In order to better understand how to optimize malaria control tools, it is important 
to understand the transmission of malaria to locate targets for interventions and 
treatments. The Plasmodium life cycle and its transmission between mosquitoes and 
humans have been prominent topics of several malaria reviews, and an overview of the 
cycle can be seen in Figure 2. Plasmodium is a unicellular, obligate parasite, which 
means that it cannot grow or reproduce without a host (Kaushansky & Kappe, 2015; 
Kooij & Matuschewski, 2007). This parasite has a complex life cycle that requires both a 
human host and a female Anopheles mosquito to complete its life cycle (Cowman et al., 
 
8 
2016; Meibalan & Marti, 2017). A human will become host to Plasmodium parasites 
after an infectious mosquito bite, thus starting Plasmodium asexual reproduction. 
Sporozoites, the infectious form of the parasites transmitted from the mosquito to human, 
will migrate to the liver, where they can undergo a series of mitotic divisions to form 
merozoites (Cowman et al., 2016; Meibalan & Marti, 2017). Merozoites invade the RBCs 
in a series of receptor-ligand interactions, which Weiss et al., in their 2015 paper has 
shown to have specific roles and afflict morphological changes on the RBCs in the 
process of parasite invasion (Weiss et al., 2015). In P. vivax and P. ovale, where the 
parasite typically goes into a long period of dormancy and can relapse over years without 
parasite detection, the sporozoites form into dormant hypnozoites in the liver until they 
are reactivated to produce merozoites, a process that is likely activated due to stress (Z. 
Liu et al., 2011; Milner, 2018; Mueller et al., 2009). In P. falciparum, the parasites do not 
undergo long periods of dormancy and forgo the hypnozoite form (Aly et al., 2009; 
Cowman et al., 2016). P. vivax gametocytes, the mosquito-infecting form of Plasmodium, 
tend to develop before any clinical symptoms appear, making its transmission difficult to 
prevent and the disease difficult to treat, requiring a 7-14 day anti-malarial treatment 
course that targets both the liver and blood parasite stages (Ferreira & Castro, 2016; Z. 
Liu et al., 2011). Given the difficulty controlling transmission on the human side, it is 






Figure 2 Life cycle of Plasmodium parasites in the human host and Anopheline vector. 
(A) The mosquito takes a blood meal that deposits infectious Plasmodium sporozoites in 
the human. (B) Pre-erythrocytic cycle: Sporozoites infect liver cells in the human, where 
they can remain dormant as hypnozoites (P. vivax) or form merozoites that will infect 
RBCs. (C) Erythrocytic cycle: Parasites replicate asexually and infect other RBCs, once 
again repeating the erythrocytic cycle. (D) Gametocytogenesis: Some of parasites will 
undergo gametocytogenesis, leading to the development of infectious gametocytes that 
are the infectious components of a mosquito blood meal. (E) Sporogonic cycle: 
Plasmodium gametocytes are activated into macrogametes and microgametes, sexual 
stages of the Plasmodium parasite, and the sexual combination of these two forms will 
form ookinetes, which develop into oocysts. Oocysts develop in the mosquito midgut and 
will produce thousands of sporozoites that, when oocysts rupture, will be released into 
the mosquito salivary gland, allowing mosquitoes to infect humans when it takes a blood 




Vector control strategies rely on an understanding of mosquito-parasite 
transmission and interaction. Gametocytes are the infectious form of Plasmodium in 
human blood that is taken up by blood-feeding Anopheles mosquitoes to propagate the 
cycle of malaria transmission. During normal asexual replication, a few parasites will 
deviate from the normal cycle and form gametocytes, which are sexual forms of the 
parasite. The infectious bloodmeal is transferred into the mosquito midgut, and within 
minutes, the gametocytes begin the sporogonic cycle, the sexual replication of 
Plasmodium, by egressing from the human RBCs and differentiating from gametocytes 
into gametes (Meibalan & Marti, 2017). The formation of gametocytes in humans is 
typically triggered by environmental stress, which can be due to levels of parasitemia in 
the host, the presence of host-immune response, and hematological disruptions in the 
form of anemia, RBC lysis, and increase in erythropoietin and reticulocyte production (Z. 
Liu et al., 2011). Gametogenesis, the differentiation and the activation of gametocytes 
into male and female gametes, is triggered by a drop in the temperature in mosquitoes as 
compared to the temperature in humans and by an increase in xanthurenic acid 
concentration, along with other factors in the mosquito midgut (Aly et al., 2009; 
Meibalan & Marti, 2017). The male gametes, also known as microgametes, will 
exflagellate and produce eight motile microgametes that fertilize female gametes, or 
macrogametes, to form a diploid zygote (Mitchell & Catteruccia, 2017).  
As seen in Figure 3, the zygote will develop into a motile ookinete, allowing the 
parasite to penetrate the midgut wall into a space between the midgut epithelium and the 
basal lamina. This process typically occurs between 18 to 24 hours after the blood enters 
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the midgut. Once the ookinete breaches the midgut epithelium, it will encyst and 
differentiate into an oocyst, which occurs at around 48 hours after the infectious blood 
meal (Mitchell & Catteruccia, 2017; Smith & Jacobs-Lorena, 2010). Over the course of 
the next 2 weeks, the oocysts will undergo sporogony, a process involving rapid cell 
division and where between 2000 and 8000 sporozoites are produced from within a single 
oocyst. At around day 14, the oocysts release sporozoites into the hemolymph, from 
where some sporozoites will eventually invade the salivary glands. Upon the biting of an 
infectious mosquito, the saliva from the salivary glands, mixed with the sporozoites, will 
enter the human body, further spreading the cycle of malaria transmission (Mitchell & 
Catteruccia, 2017; Sinden, 2002; Smith & Jacobs-Lorena, 2010). This process of 
producing infectious sporozoites occurs over a period of approximately 10 to 14 days 
after an infectious blood meal, during which only a few females may potentially survive 
to transmit malaria (Mitchell & Catteruccia, 2017). Sporozoites, after bursting from the 
oocysts, are released into the mosquito hemocoel and circulate throughout the mosquito 
body via the hemolymph. The sporozoites, through specific receptor-ligand interactions, 
will adhere to the salivary glands of the mosquito and invade the salivary glands, making 
the mosquito capable of transmitting the parasite (Aly et al., 2009). The circumsporozoite 
protein has an especially important role in sporozoite function, contributing to sporozoite 
development and mediating the processes of salivary gland and liver cell invasions. As a 
surface protein on both maturing oocysts and sporozoites, it is a commonly used target of 
immunofluorescent assays to visualize the development of oocysts and sporozoites 
(Vlachou et al., 2006). Both ookinete invasion into the midgut and sporozoite invasion 
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into the salivary glands are known bottlenecks for the parasite survival and should be 
further studied as potential targets against malaria transmission (Smith et al., 2014; 
Whitten et al., 2006).  
The development of P. falciparum in A. gambiae mosquito midguts coincides 
with A. gambiae egg development, both of which can only occur with the ingestion of a 
blood meal (Mitchell & Catteruccia, 2017). In a recent study, Werling et al., observed a 
non-competitive relationship between A. gambiae and P. falciparum, which was 
highlighted through the observation of a positive correlation between Anopheles egg 
development and oocyst intensity after an infectious blood meal (Werling et al., 2019). 
The authors further demonstrated that this relationship was mediated by the mosquito 
through 20-hydroxyecdysone (20E) steroid hormone signaling. This observation was 
surprising because previous studies have determined that malaria parasites exert a cost of 
fitness on Anopheles mosquito, thus reducing mosquito survival. A meta-analysis done in 
2002 concluded that while malaria parasites do exert a cost of fitness on Anopheles 
mosquitoes, this relationship was mainly seen in unnatural mosquito-parasite pairings 
(Ferguson & Read, 2002). This study of Werling, et al., however, was carried out with 
natural mosquito-parasite pairing of A. gambiae and P. falciparum. The lack of observed 
fitness costs in this natural mosquito-parasite pairing could explain P. falciparum’s 
impressive spread in Sub-Saharan Africa (Werling et al., 2019). This highlights the 
importance of 20E and Anopheles egg development when looking at Plasmodium growth 




Figure 3 Egg development and Plasmodium gametogenesis occur simultaneously. These 
two processes are both tied to the intake of a blood meal. This figure shows the timeline 
of mosquito egg development and oviposition, and the timeline of Plasmodium 
development into sporozoites. A female Anopheline takes multiple blood meals 
throughout her life and develops then lays the eggs during each blood meal-induced 
gonotrophic cycle. At around days 12 through 14, sporozoites have burst from their 
oocysts, so mosquitoes are capable of infecting human hosts in their next blood meal. 
Adapted with permission. (Mitchell & Catteruccia, 2017)
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The steroid hormone, 20E, mediates the observed positive correlation in egg 
development and in P. falciparum development in A. gambiae (Werling et al., 2019). 
Increased levels of 20E is seen after mating, when the sexual transfer of a mating plug 
containing male-derived 20E renders the female refractory to mating (Gabrieli et al., 
2014). Despite the monandrous mating behavior of Anopheles females, mated females are 
able to develop and lay eggs each time they take a blood meal, which induces the 
production of 20E in Anopheles females (Mitchell & Catteruccia, 2017). When 20E 
interacts with the receptor complex: ecdysteroid receptor (EcR) and the ultraspiricle, it 
triggers a number of reproductive signals, such as egg development, lipid accumulation in 
the ovaries, and egg laying (Swevers, 2019). Given the huge role of 20E on the 
reproductive characteristics of Anopheles mosquitoes, the 20E pathway could be a 
potential target for controlling vector populations and malaria. However, caution must be 
taken when targeting the 20E pathway for malaria control, as the results from Werling et 
al., have shown that in silencing EcR, P. falciparum tend to have fewer oocysts per 
midgut but faster oocyst growth and sporozoite development, which could lead to faster 
malaria transmission; no effect was seen on the prevalence of infection (Werling et al., 
2019). Given that normal Anopheles females only become infectious in 11-14 days after 
an infectious blood meal and that a typical female Anopheles lifespan is around 2-3 
weeks, faster parasite growth can be extremely detrimental to malaria eradication efforts 
(Clements & Paterson, 1981). With faster parasite development, a greater proportion of 
female mosquitoes in a given population will be infectious at a given time.  
 
15 
In a recent study, A. gambiae females exposed to methoxyfenozide (MET), a 20E 
agonist, exhibited different effects on P. falciparum infection. Virgin female A. gambiae, 
G3 mosquitoes were treated with MET, a compound within the class of 
dibenzoylhydrazines (DBH). MET successfully decreased the prevalence of mosquitoes 
infected with NF54 P. falciparum when it was topically applied on the thorax of the 
mosquito. In addition to its activity against malaria infections, increasing concentrations 
of MET led to decreased egg development, apoptosis of ovarian follicles, reduced 
lifespan, and prevention of virgin female Anopheles mosquitoes from initiating mate-
seeking activities (Childs et al., 2016). In a 2012 study, DBH compounds including MET, 
were shown to have insecticidal activity against Anopheles larvae. MET was shown to 
have the greatest toxicity when compared to the other compounds tested but is non-toxic 
to humans (Morou et al., 2013). MET’s larvicidal qualities along with its observed effects 
against P. falciparum infection in A. gambiae females, made it a candidate in the search 
for new compounds to use in malaria and vector control.  
 
III. Malaria Control and Resistance to Insecticides and Antimalarials 
Malaria is one of many vector-borne diseases, with some other examples being 
chikungunya, West Nile virus, and Zika virus. In a 2019 review published by Nature 
Microbiology, Shaw and Catteruccia described vector control as the most effective 
method of stopping mosquito-borne diseases, which is in concordance with the WHO’s 
belief that mosquito control can prevent and bring malaria transmission close to zero 
(Shaw & Catteruccia, 2019; WHO, 2020a). In malaria-endemic regions, insecticide-
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treated nets (ITNs), indoor residual sprays (IRS), and artemisinin combination therapies 
(ACTs) have all contributed to the decline in transmission (WHO, 2019b). Their 
contributions are explored in a 2015 Nature paper, where Bhatt et al., modeled the effects 
of using these three interventions on the decrease in the prevalence of malaria cases 
between 2000 and 2015. All three interventions contributed to the decrease in the 
prevalence of disease when compared to a counterfactual (i.e., no intervention) trend, and 
ITNs had the greatest predicted impact in contributing to the number of cases averted and 
in decreasing the prevalence of the disease. In fact, ITNs are predicted to have been 
responsible for as much as 68% of the decrease in malaria cases between 2000 and 2015 
(Bhatt et al., 2015). ITNs and IRS are the main and most effective forms of vector control 
currently used, and ACT is currently the most effective treatment against P. falciparum in 
humans. Although these tools have greatly shaped malaria control strategies, more 
research still needs to be done to fully optimize their effects.  
 
3.1 Insecticide-Treated Nets and Long-Lasting Insecticide-Treated Nets 
Vector capacity estimates the ability of a vector to transmit pathogens to humans. 
Six factors are involved in this equation—vector density, vector biting rate, vector 
competence, vector daily survival probability, pathogen incubation period, and vector 
lifetime survival. ITNs and IRS work to decrease the factors mentioned in the vector 
capacity equation to limit the mosquito’s capacity to transmit malaria (Shaw & 
Catteruccia, 2019). ITNs provide a protective barrier for people sleeping under them, but 
they have also been shown to have a community effect, where members of the 
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community that aren’t sleeping under a net are also protected due to decreased mosquito 
survival (WHO, 2019b).  While one study observed the community effect in non-net 
users, they heavily emphasized the need for better surveillance to prove that this effect 
does exist; another study did not observe a community effect in non-net users 
(Komazawa et al., 2012; Quiñones et al., 1998). Nonetheless, when ITNs are used, the 
prevalence of P. falciparum infections was reduced by 17% compared to when no nets 
were used, and when compared to non-treated nets, ITNs reduced the prevalence by 10% 
(Pryce et al., 2018). This shows that ITNs have improved the health outcomes of at-risk 
populations in malaria-endemic regions.  
ITNs are traditionally impregnated with a class of insecticides called pyrethroids, 
which are commonly used because they are shown to have fewer toxic effects at certain 
doses against humans than other insecticide classes (Zaim et al., 2000). A recent study, 
however, suggested that these pyrethroids might not be free of adverse effects at low 
doses and should be used with caution (Chrustek et al., 2018).  One of the newer forms of 
ITNs are long lasting insecticide-treated nets (LLINs). LLINs are impregnated with the 
insecticide and must survive 20 washes and 3 years of use under field conditions; this 
makes re-treating ITNs unnecessary (de Oliveira Sousa et al., 2019). Two common 
insecticide formulations are used on LLINs: 1) pyrethroid insecticide only, such as the 
OLYSET® net consisting of only permethrin, and 2) pyrethroid insecticide with 
piperonyl butoxide (PBO) synergist, such as the OLYSET Plus® net consisting of 
permethrin and PBO (WHO, 2020b). The OLYSET® nets are only two nets amongst 
many other nets with different combinations of insecticide and PBO. PBO has been used 
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for the past few decades in agricultural settings as a synergist to enhance the activity of 
insecticides through two mechanisms: 1) inhibiting metabolic enzymes in mosquitoes, 
such as P450s and non-specific esterases, and 2) enhancing the insecticide penetration of 
mosquito cuticles (Bingham et al., 2011). A study showed that the addition of PBO to the 
LLINs completely restored susceptibility of a sample of A. funestus despite heavy 
pyrethroid resistance in these mosquitoes (Churcher et al., 2016; Sinka et al., 2012). 
Despite its success in enhancing insecticide uptake, PBO is also a possible human 
carcinogen, thus, making it potentially dangerous as a compound in LLINs and must be 
used cautiously. Taking into account PBO’s potential carcinogenic effects, a study done 
by Marchand, et al., showed that vegetable oils, such as rapeseed methyl ester (RME), 
can be just as effective as PBO in working as a synergist for insecticide uptake 
(Marchand et al., 2018). In a recent study from Lees, et al., researchers showed that RME 
enhanced the tarsal uptake of several insecticides, activating 11 compounds—previously 
ineffective in tarsal contact assays —with the addition of RME (Lees et al., 2019). RME 
has potential to enhance tarsal uptake and could potentially be a solution to making 
previously ineffective insecticidal compounds, effective.  
Previously, pyrethroids were the only insecticide class used on bed nets and the 
most popular insecticide for IRS. Recently, other compounds have been explored: 
chlorfenapyr, a pro-insecticide that becomes active in the host, and pyriproxyfen, a 
juvenile growth hormone mimic that is commonly used as a larvicide, have been shown 
to be effective insecticides against Anopheles mosquitoes (N’Guessan et al., 2016; 
Ngufor et al., 2014). In N’Guessan’s study, they formulated an LLIN mixture, 
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Interceptor® G2, that combines a pyrrole, chlorfenapyr, and a pyrethroid, alpha-
cypermethrin, and they tested this mixture against pyrethroid-resistant A. gambiae. The 
results were promising, showing that the mixture killed 71% of permethrin-resistant A. 
gambiae as compared to an alpha-cypermethrin-only mixture that killed only 20% of 
permethrin-resistant A. gambiae, and after 20 washes, the mixture killed 65% of 
permethrin-resistant A. gambiae (N’Guessan et al., 2016). As seen from the incomplete 
killing by the Interceptor® G2 on pyrethroid-resistant A. gambiae, it may be that there is 
already some form of resistance against the chlorfenapyr, despite its higher efficacy in 
decreasing survival. This further emphasizes the need for more research on insecticides 
and insecticide resistance to improve the efficacy of control tools. The use of 
pyriproxyfen in a new LLIN product, the Olyset Duo®, consisted of a combination of 
pyriproxyfen and permethrin, a pyrethroid compound (Ngufor et al., 2014). They 
observed that Olyset Duo® LLINs provided greater protection for children participating 
in their study in Burkina Faso relative to pyrethroid only LLINs, reducing a normal 85 
average bites per infection season to only 42 infective bites per infection season (Tiono et 
al., 2018). Both of the new LLINs take into account the recommendation to not rely 
solely on pyrethroids and to combine different classes of insecticides in LLIN 
formulations (Weedall et al., 2019). Ultimately, the same principles apply for IRS: There 
needs to be more diverse combinations of insecticide classes in IRS mixtures. LLINs and 
IRS must use insecticides that both work on mosquitoes and have limited adverse effects 
on humans, hence their strong reliance on pyrethroids. Yet, there are 5 other classes that 
have been recommended for use against adult mosquitoes: organophosphates, 
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carbamates, organochlorines, and pyrroles, and phenyl pyrazoles, that must still be better 
explored (Liu, 2015). However, there have been increasing reports of resistance against 
these classes of insecticides as well (Ranson & Lissenden, 2016). Other forms of 
compounds, such as insect growth regulators and known agricultural pesticides, are also 
currently being explored for malaria control uses. The heavy reliance on pyrethroids in 
the past has built heavy resistance against the insecticide in many places worldwide, 
rendering the LLINs and IRS less effective, so it is important that more research must be 
done to find alternatives compounds for vector control tools.  
Despite the number of cases averted by these interventions, the incidence of 
malaria cases has remained stagnant since 2014, which could be due to increasing 
resistance against antimalarials and insecticides (WHO, 2019b). There are many ways 
insecticide resistance can occur in mosquitoes, three of which are common: 1) metabolic 
resistance, 2) cuticular resistance, and 3) target site resistance; a fourth mechanism of 
resistance, behavioral resistance, has been observed as well (Ranson et al., 2011). 
Metabolic resistance occurs when enzymes that detoxify the insecticides are 
overexpressed in the presence of stressors.  Commonly seen detoxification enzymes 
include P450 monooxygenases, glutathione-S-transferases, and carboxylesterases (Toé et 
al., 2015). The cytochrome P450 genes are often overexpressed in pyrethroid resistant 
mosquitoes. Mosquitoes with the cytochrome P450 pyrethroid-resistant allele 
CYP6P9a_R, which is found mainly in a major African malaria vector A. funestus, 
showed increased survival and success in blood feeding despite the presence of 
pyrethroid insecticides found on ITNs. This allele has evolved to build metabolic 
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resistance against insecticides (Weedall et al., 2019). Cytochrome P450s are also 
associated with cuticular resistance, which occurs when mosquitoes are not able to take 
up insecticides due to the insecticides’ inability to pass through the mosquito cuticular 
barrier. It is involved in the production of cuticular hydrocarbons, the compounds that 
make up the mosquito cuticles. Increased cuticular hydrocarbons provide a thicker barrier 
against insecticides, making insecticides unable to enter the mosquito through tarsal 
contact (Balabanidou et al., 2016).  
Tarsal contact is a key component for the effectiveness of IRS and LLINs, and 
cuticular resistance, which directly affects the ability to take up insecticides via tarsal 
contact, is a threat to the effectiveness of these tools. Target site resistance, which is 
commonly called knock-down resistance, occurs when the target sites become insensitive 
to the insecticides due to changes in the target site structure or due to point mutations 
(Liu, 2015). Resistance is extremely detrimental to the progress made in malaria 
eradication in the past decades, and more research must be done to understand the 
implications of insecticide resistance and find better tools to overcome this barrier.  
These forms of insecticide resistance have built up over time through the poor 
management of insecticide-use and using compounds that focus on the same target, rather 
than a diversity of targets. Vector control through insecticides must use a variety of 
compounds that have assorted targets to ensure mosquito death and resist building 
resistance. In light of the resistance that has built up against insecticides in LLINs and 
IRS, researchers are now looking towards repurposing already-existing insecticides that 
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were not previously used for vector control (Lees et al., 2019). There is still much work 
to do be done on finding different classes of compounds to use on vector control tools.  
 
3.2 Artemisinin Combination Therapy and Artemisinin Resistance 
Resistance has not only developed in the mosquitoes but also in the parasites. A 
good example of this is artemisinin resistance. ACT is currently the most effective drug 
therapy used to treat Plasmodium infections. It uses the drug artemisinin in combination 
with partner drugs, such as lumefantrine, mefloquine, amodiaquine, or 
sulfadoxine/pyrimethamine, and has been successful in treating uncomplicated malaria, 
leading to a 18% decrease in the incidence of malaria cases between 2010 and 2016 (Ouji 
et al., 2018). However, the poor administration of artemisinin treatments, often using 
monotherapies of artemisinin-only drugs rather than ACT, has led to the spread of 
artemisinin resistance throughout the Greater Mekong Subregion (Miotto et al., 2013). In 
2009, the first confirmed case of artemisinin resistance was seen in Western Cambodia. 
(Fairhurst & Dondorp, 2016). In a 2014 study, the median parasite clearance half-life 
after taking an ACT in the Democratic Republic of Congo was 1.9 hours and at the 
Thailand-Cambodian border was 7 hours, which shows the effect of resistance to ACT 
(Ashley et al., 2014).  There have been no signs of artemisinin resistance outside of the 
Southeast Asia region (Rosenthal, 2018). However, the spread of artemisinin resistance is 
always a concern.  
Artemisinin resistance in P. falciparum is caused by a mutation in the kelch-13 
gene, of which the C580Y mutation is the most common mutation (Kobasa et al., 2018). 
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A 2017 study described kelch-13 and pfs-47, a P. falciparum surface membrane protein, 
to be genetically linked (Molina-Cruz et al., 2017). Pfs-47 helps P. falciparum evade the 
Anopheline immune system. (Molina-Cruz et al., 2017; Molina-Cruz & Barillas-Mury, 
2014). Thus, P. falciparum with kelch-13 mutations that lead to artemisinin resistance are 
likely to continue evading the Anopheline immune system and persist in the population. 
While ACT is no longer be as effective as it once was, vector control methods can be 
supplementary in controlling the transmission of artemisinin resistant parasites.  
 
3.3 Atovaquone and Similar Compounds 
 A recent study published in Nature shows that antimalarials can be taken up 
through tarsal contact to eliminate P. falciparum infections in A. gambiae. In this paper, 
Paton et al., exposed A. gambiae females to ATQ before feeding them an infectious P. 
falciparum blood meal. A dilution series was carried out to observe the effects in 
prevalence of infection and in oocyst intensity of P. falciparum after a 6-minute exposure 
to ATQ through tarsal contact (Figure 4). The study found that ATQ stopped a majority 
of the parasites from developing past the zygote stage, so at 100µmol/m2, no infection 
was seen in the midgut. Paton, et al., also saw a decrease (Figure 5) in the prevalence of 
infection when using the same exposure model with hydramethylnon (HYD) and 
acequinocyl (ACE) (Paton et al., 2019). ATQ is an apicomplexan-specific inhibitor of 
cytochrome bc1, which is found in the inner membrane of the mitochondria (Srivastava et 
al., 1997). ATQ’s function as a cytochrome bc1 inhibitor not only blocks ATP synthesis 
by inhibiting an integral part of the electron transport chain but also inhibits de novo 
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pyrimidine synthesis, an important and necessary process in P. falciparum DNA 
replication. It was shown that in human stages, P. falciparum development relies 
cytochrome bc1 for de novo pyrimidine synthesis and not for ATP synthesis (Painter et 
al., 2007). Thus, ATQ’s function in inhibiting the development of P. falciparum zygotes 
can be due to a lack of ATP, the inability to replicate DNA, or both. Another study 
showed that the inhibition of type II NADH:ubiquinone dehydrogenase, also a part of the 
electron transport chain, prevented ookinete maturation into oocysts (Boysen & 
Matuschewski, 2011). This further supports that the electron transport chain, an essential 
part of P. falciparum development and growth in the mosquito stages, would make a 
good target for malaria control.  
Like many of the compounds mentioned before, resistance has already developed 
against ATQ in Plasmodium parasites. ATQ resistance has previously been observed in 
human stage Plasmodium parasites; however, a 2016 study showed that mutations 
conferring resistance to ATQ in P. berghei, a rodent malaria parasite caused complete 
arrest of developing parasites during the oocyst stage, suggesting ATQ resistance 
mutations are non-transmissible (Goodman et al., 2016). Moreover, cytochrome bc1 
mutations, associated with ATQ resistance, have been shown to be linked to decreased 
fitness in P. falciparum because of the mutation’s effect on the parasite’s respiration 
(Goodman et al., 2016; Peters et al., 2002).  From these studies, ATQ resistance exerts 
costs on Plasmodium fitness, and this makes ATQ and other cytochrome bc1 inhibitors 
good candidates for tool development. HYD and ACE were used in Paton’s study 
because of their similar target as ATQ: cytochrome bc1, and they have been used as 
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pesticides in the past (Hooper‐Bùi & Rust, 2001; Paton et al., 2019). While the 2019 
study has shown that ATQ is effective in eliminating parasite infection in mosquitoes 
when the mosquitoes are exposed before an infectious blood meal, it is still unclear what 
the limits of atovaquone-treatment of Anopheline mosquitoes exposed to P. falciparum 
are. Further research must also be done to understand ATQ’s limit as a malaria vector 
control tool and on using ATQ with other vector control tools that can bypass cuticular 
resistance associated with tarsal contact.  
 
 
Figure 4 Female A. gambiae mosquitoes are exposed to ATQ for 6 minutes in a dilution 
series assay (1 mmol ATQ, 100 µmol ATQ, and 10 µmol ATQ) and given an infectious 
blood meal right after the ATQ exposure. Midguts are dissected and imaged for the 






Figure 5 Female A. gambiae mosquitoes were exposed to 1mmol per m2 of either ATQ, 
HYD or ACE, for 6 minutes and then fed an infectious blood meal. The midguts are 
dissected, and the oocyst intensity and prevalence of infection are measured on day 7 
pIBM. Adapted with permission. (Paton et al., 2019) 
 
3.4 Attractive Toxic Sugar Baits  
Attractive toxic sugar baits (ATSBs) are an increasingly popular tool for 
controlling mosquito populations. Especially since ITNs and IRS both target mosquitoes 
that feed and rest indoors, it is limited in its uses because not all malaria-carrying 
mosquitoes feed and dwell indoors (Ranson et al., 2011). Additionally, there has been 
anecdotal reports of behavioral resistance, claiming an increase in outdoor-feeding 
mosquitoes due to the increase in insecticide-use indoors, this was later supported by an 
individual-based modelling study in 2017 (Bøgh et al., 1998; Ranson et al., 2011; Zhu et 
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al., 2017). Sugar baiting can target both outdoor and indoor environments and behavior of 
the mosquito to deter certain behaviors (such as biting) and can induce mosquito death. 
Insect baiting is not a new concept, having existed since before 77 AD, and adding 
attractants and feeding stimulants are also concepts seen in the past (Fiorenzano et al., 
2017). However, with the goal of distributing ATSBs as a worldwide effort to reduce 
mosquito-borne diseases, ATSB-use needs to be further studied to understand how to 
fully optimize the tool and reduce its effects on non-target insects.  
 ATSBs can be a powerful tool for malarial control because, unlike other tools 
currently in circulation, ATSBs target both male and female mosquitoes rather than just 
the biting adult females, showing significant reduction in both population’s survival after 
ATSB exposure (Maia et al., 2018; Qualls et al., 2015). In many studies, ATSBs have 
successfully reduced the mosquito population and decreased the number of older female 
mosquitoes, a population known to have a greater chance of malaria infection, and the 
number of sporozoite-transmitting mosquitoes (Qualls et al., 2015; Traore et al., 2020). 
Mosquitoes acquire their sugar meals from a variety of plants, mainly flowers, fruits, and 
seed pods. In a study done on the attractive component of ATSBs, it was observed that 
ripe guava and honey melons were especially attractive to A. gambiae (Müller et al., 
2010).  Many studies have observed species-specific preferences in the field, with 
growing evidence supporting the relationship between plant sugar availability and 
mosquito fitness (Airs et al., 2019; Foster, 1995). While many studies have been done to 
assess sugar preference of the mosquitoes, little research has been done on how sugar 
composition is distributed in the mosquito gut system and how a sugar composition 
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affects the attractiveness of ATSBs in A. gambiae. In a 2019 study published in Acta 
Tropica, Airs, et al. showed that most sugars distributed into the ventral diverticulum, 
also known as the crop, in Aedes aegypti mosquitoes, and in those same mosquitoes, 
arabinose, lactose, and cellobiose significantly decreased their survival when compared to 
mosquitoes fed with sucrose (Airs et al., 2019). When using ATSBs to target A. gambiae 
populations and P. falciparum infections, knowing the sugar composition and how 
different sugars distribute could elucidate where the drugs and insecticides used in 
ATSBs will end up and whether there are any unexpected reactions between the attractive 
sugar source and the insecticides/drugs.  
In many villages where malaria is endemic, LLINs and IRS are not sufficient to 
controlling malaria, and a 2017 study concludes that ATSBs should be incorporated in 
vector control given that there was significant reduction when using both LLINs and 
ATSBs as compared when using only LLINs (Zhu et al., 2017). One of the dangers of 
using ATSBs is its non-specific targeting of other insects that might be beneficial to the 
environment, but a 2017 review concluded that the effects of ATSBs on non-target 
arthropods are limited (Fiorenzano et al., 2017). Nonetheless, it is important to exercise 
caution in deciding what kinds of insecticides and drugs to include in ATSBs. More 
studies must be done on diversifying the insecticides used in ATSBs, just as current 






As vector control is an effective method of malaria transmission control and 
prevention, it is important to place importance on testing compounds that could be used 
in vector control tools. Two tools that are of great interest are ITNs, which requires tarsal 
contact for the exposure compound to be effective, and ATSBs, which requires ingestion 
of a compound-treated sugar meal to be effective. This thesis will be looking at the 
natural parasite-mosquito pairing, P, falciparum and A. gambiae.  
Aim 1: Determine the effects of ATQ-treated sugar feeding on P. falciparum 
infection in A. gambiae when mosquitoes are treated before and after an infectious blood 
meal.  
Aim 2: Determine the effects of HYD-treated sugar feeding on female A. gambiae 
survival and on P. falciparum infection in A. gambiae when mosquitoes are treated 
before an infectious blood meal 
Aim 3: Determine the effects of MET exposure through tarsal contact on P. 
falciparum infection in A. gambiae and on A. gambiae egg development when 
mosquitoes are exposed before an infectious blood meal and the effects of MET-treated 
sugar feeding on A. gambiae egg development when mosquitoes are exposed before a 
blood meal.  
These 3 aims will help define the limits of the three compounds: ATQ, HYD, and 
MET, on their efficacy and potential use in vector control tools through either sugar 





METHODS AND MATERIALS 
 
I. Insect Lines and Rearing 
The mosquitoes used in these experiments were reared in the insectary at the 
Harvard T.H. Chan School of Public Health. Wild type A. gambiae, G3, mosquitoes were 
used. All A. gambiae mosquitoes were kept in an insectary at 27°C and 80% relative 
humidity on a 12-hours light and 12-hours dark cycle to replicate field-like conditions. 
Adults were kept in large colony cages (Bugdorm Megaview Science, Taichung, Taiwan) 
and provided 10% w/v glucose solution ad libitum. All cages were provided with water 
and a plastic cover to maintain stable humidity. For colony maintenance, 5-7 days after 
eclosure from their pupae form, adult female mosquitoes were provided with human 
blood meals using an artificial membrane feeding system (Hemotek, Accrington, UK). 
All human blood samples were donated voluntarily (Research Blood Components, 
Boston, MA).  
 
II. P. falciparum infection assays 
For infection, female mosquitoes were separated from the males as pupae in order 
to obtain virgin adult female mosquitoes. Non-virgin adult female mosquitoes can be 
taken from a mixed cage using a HEPA-filter mouth aspirator (J.W. Hock, Gainesville, 
FL). P. falciparum NF54 parasites were used in all infections (BEI resources, Manassas, 
VA). The parasites were cultured in asexual stages between 0.2% and 2% parasitemia at 
37°C in human RBCs at 5% hematocrit supplied by the Interstate Blood Bank (Memphis, 
TN). This parasite culture solution was comprised of RPMI 1640 with 25mM HEPES, 10 
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mg/L hypoxanthine, 0.2% sodium bicarbonate, and 10% heat-inactivated human serum 
(Interstate Blood Bank, Memphis, TN) under a gas mixture of 5% O2, 5% CO2, balanced 
N2 for up to 8 weeks (Ifediba & Vanderberg, 1981; Trager & Jensen, 1976). 
Gametocytogenesis was induced before infecting the mosquitoes. This was done 
by raising parasitemia above 4% and incubating the cultures for 14-20 days to accrue 
stage IV and V male and female gametocytes. The media was replaced daily. Mosquitoes 
were placed in small cages (Bugdorm, Megaview Science, Taichung, Taiwan) and fed 
infectious blood in a sealed, secured infection glovebox through a glass, water-heated 
membrane feeder for 60 minutes (Hemotek, Accrington, UK). The female mosquitoes 
that were visibly unfed were vacuum aspirated into 80% ethanol and discarded within 12 
hours of the infectious blood meal. The remaining mosquitoes were left in the secure 
glovebox and provided 10% w/v glucose solution ad libitum, refreshed every 3-5 days, 
unless otherwise specified.  
In most experiments, the mosquitoes were aspirated on day 7 after an infectious 
blood meal, which is sufficient for looking at oocyst development and prevalence of 
infection. In specific experiments however up to 10 days after infection may have been 
examined.  When collecting salivary glands for sporozoite data, mosquitoes were 
aspirated into RPMI medium on day 14 or later after an infectious blood meal.  
 For observing the number and size of oocysts in female mosquito midguts, the 
mosquitoes in 80% ethanol were incubated for 10 minutes at -20°C and then removed 
from the ethanol and put into 1x PBS (made from a 10x PBS and ddH2O solution). The 
midguts were dissected from the mosquito using a pair of forceps and a surgical needle 
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and stained with 2mM mercurochrome in ddH2O for 15 minutes. After staining, the guts 
were mounted on glass microscope slides in 0.2mM mercurochrome and examined at an 
object of 40x on an inverted compound light microscope (Olympus).  
For observing the number of sporozoites, infected mosquitoes were decapitated in 
the secure glovebox before removal from the box. The salivary glands were dissected in 
RPMI medium from the mosquitoes and placed into Eppendorf tubes with RPMI 
medium. The salivary glands were individually ground by pestles and subsequently spun 
via centrifugation at 8000 g for 10 minutes at 4°C to release the sporozoites. The 
supernatant fluid was disposed of and the remaining pellet was resuspended in a known 
volume of RPMI or 1x PBS. A 10µL solution of the sporozoites suspended in fluid was 
pipetted into disposable hemocytometers (Fischer Scientific), and sporozoites in 0.1µL 
were counted at 400x magnification using phase-contrast on an inverted compound 
microscope (Olympus). The total sporozoites per mosquito was calculated from the 
0.1µL sample.  
 
III. Exposures (Tarsal contact and sugar feeding) 
The compound MET (Sigma-Aldrich), used in tarsal contact exposures was 
dissolved in acetone, a volatile vehicle, at stock concentrations of 3-10 mg ml-1 (0.3-1% 
w/v). These stock solutions were diluted to create the desired concentrations needed for 
the experiments. A known volume of the solutions containing the MET was added to 
500µL excess of acetone and applied onto a glass petri dish (area = 0.0283 m2). In the 
case where RME was added, the RME, also dissolved in acetone to a 100µmol/L 
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concentration, was added to excess of acetone before a known volume of MET dissolved 
in acetone was added. The treated plates were left for at least 4 hours on a lateral shaker 
until the acetone evaporated. Control plates were also given acetone with no compounds 
added, and the same treatment was applied. A plastic cup was inverted over the glass 
dish, and a flap was cut into the base of the cup in order to aspirate mosquitoes into 
contraption. A HEPA-filter mouth aspirator (J.W. Hock, Gainesville, FL) was used to 
aspirate 25-30 mosquitoes onto the glass dish, and the mosquitoes were incubated for 60 
minutes. The plates were agitated every 15 minutes to make sure the mosquitoes were 
landing on the plate rather than clinging onto the untreated plastic cup. Once the exposure 
was completed, the mosquitoes were transferred into a small cage by opening the entire 
dish contraption inside of the cage.  
Compounds, ATQ, MET, and HYD used in sugar feeding assays were dissolved 
in DMSO to form a stock concentration of 20nM, and dilutions were made from the stock 
solution before being added to 10mL of 10% w/v glucose solution. The final glucose 
solutions had 0.5% DMSO, which was taken from the stock solution within which the 
compounds were dissolved.  Controls were given a similar 10 mL of 10% w/v glucose 
solution with 0.5% DMSO. Cotton pads were soaked with the 10 mL sugar solutions and 
placed in small plastic dishes. When working with non-infected mosquitoes, mesh netting 
was placed on top of these cotton pad dishes, and the dishes were placed into the 
mosquito cages. When working with infected mosquitoes, the sugar dishes were inverted 
over the top of the cage without any mesh netting. The sugars were left on or in the cage 
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from anywhere between 24 hours to 14 or more days, depending on the experiment, and 
they were changed every 3-4 days.  
 
IV. Survival assays 
Survival was assessed for HYD sugar feeding exposures. Around 40 female 
mosquitoes were placed in small cages and exposed for 24 hours to a dilution of HYD 
(100µM, 10µM, and 1µM) and subsequently provided 10% w/v glucose solution. Water 
was also given after the exposure was removed for added humidity. Survival was 
measured daily 24 hours after the exposure was administered by counting and removing 
all of the dead mosquitoes in the cage at a 24-hour time point. The experiments continued 
until all of the mosquitoes died.  
 
V. Egg development and Oviposition assays 
 Female virgin mosquitoes were exposed to MET for an hour immediately before 
their infectious blood meal via tarsal contact. A blood meal, infectious or noninfectious 
blood, was given to the mosquito using the methods above, and non-blood fed female 
virgin mosquitoes were removed. After 7 days, the gravid female virgin mosquitoes were 
collected, and their ovaries were dissected out in 1x PBS. Gentle agitation allowed the 
ovaries to release the developed eggs, and the eggs were counted. Virgin females must be 
used in order to prevent egg laying before counting the eggs at day 7. For oviposition 
experiments, female virgin mosquitoes were exposed to 1mmol/m2 MET via tarsal 
contact and given a blood meal, using an artificial membrane feeding system, 24 hours 
 
35 
after the exposure. After 48 hours, the mosquitoes were placed in oviposition cups, a 
paper cup with filter paper lining the side and a bit of water at the bottom of the cup. The 
mosquitoes were provided 10% w/v glucose solution, and five days after the blood feed, 
the laid eggs and eggs still inside the mosquito ovaries were counted.  
 
VI. Measurement of Ecdysteroid levels 
Groups of female virgin mosquitoes were exposed to 1mmol per m2 MET for an 
hour, 24 hours before their blood feed or right before receiving their blood meal using an 
artificial membrane feeding system. At 24 hours post blood meal, when 20E levels are 
typically the highest, the female virgin mosquitoes were decapitated, and the rest of the 
bodies were stored in 80µL of 80% methanol at -80°C. The 20E levels were measured 
using the 20E enzyme immunoassay (EIA) kit (Cayman Chemical, Ann Arbor, MI) using 
the protocol provided by the kit. The EIA plates were read on a spectrophotometer at 412 
nm at 90 minutes.  
 
VII. Statistical Analysis  
 The statistical analysis performed in the GraphPad Prism v. 8.1.2. for MacOSX, 
except for the survival analysis, which was done using JMP Pro 14 (SAS Institute). When 
comparing the median oocyst intensity (or intensity of infection) between two groups, a 
Mann-Whitney mean ranks test was used due to its non-parametric nature. When 
performing multiple comparisons on the median oocyst intensity amongst various groups, 
a Wilcoxon with Dunn’s post-hoc multiple comparisons test was used. An unpaired T-
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test was used to compare egg development counts per mosquito and sporozoites counts 
per mosquito between two groups due to their parametric nature. The ordinary one-way 
ANOVA along with the Sidak’s multiple comparison test was used for multiple 
comparisons for parametric data. For comparing prevalence of infection between two 
groups, a chi-squared test was used to determine the significance of the infection. For 
comparing the prevalence of infection amongst multiple groups, a Fisher’s exact test that 
was corrected for multiple comparisons (Bonferroni) was used. Chi-squared analysis was 
used to analyze the differences in survival amongst the various groups of HYD-exposed 
mosquitoes and the controls. A log-ranked Mantell-Cox test was used to analyze the 








I. ATQ exposure through sugar feeding on A. gambiae before an infectious blood 
meal resulted in a dose-dependent decrease in P. falciparum prevalence of infection.  
 
Previous research has shown that ATQ has an antimalarial effect on infected 
mosquitoes through tarsal contact (see Figure 4, above). While these effects can be used 
to improve current malarial control tools, it is still unclear to what extent ATQ can be 
used in malaria control tools other than LLINs. For this reason, ATQ’s effects on parasite 
development in A. gambiae females was studied in ATSBs. As females take essential 
sugar meals prior a blood meal, the effects of ATQ-treated sugar feeding prior to an 
infectious blood meal was studied. Mosquitoes, starved for 24 hours to incite hunger, 
were exposed to ATQ-treated sugar for 24 hours ad libitum (Figure 6). ATQ was 
dissolved in 0.5% DMSO to solubilize the compound, making it easier to dissolve in the 
10% w/v glucose solution. Shortly after the 24-hour exposure, the females were fed a 
NF54, P. falciparum blood meal. Non-blood fed females were removed after the feed to 
remove chances of a negative infection phenotype (no oocysts in the midgut) due to 
nonfeeding. At day 7 pIBM, the oocysts were visible when stained with mercurochrome, 




Figure 6 Pre-infection sugar-feeding assay: A. gambiae females are starved for 24 hours 
before they are fed a compound-treated sugar meal for 24 hours. Immediately after 
removing the exposure, A. gambiae females are given an infectious blood meal, and 7 
days pIBM, the prevalence of P. falciparum infection and P. falciparum infection 
(oocyst) intensity is measured.  
 
Previous unpublished data (Figure 7) from our lab has shown that feeding female 
A. gambiae 100µM ATQ + 0.5% DMSO in a 10% glucose solution ad libitum for 24 
hours before an infectious blood meal leads to a complete block of P. falciparum 
infection by day 7 (two-sided Fisher’s Exact Test, n = 111, p < 0.0001). This result is 
similar to the inhibition of infection seen in tarsal contact when A. gambiae females were 




Figure 7 Preliminary data (from Douglas Paton, personal communication, 2019) that 
shows the oocyst intensity and prevalence of infection of P. falciparum after A. gambiae 
females are exposed to 100µM ATQ + 0.5% DMSO-treated sugar (10% glucose solution) 
ad libitum for 24 hours right before an infectious blood meal. Oocyst intensity and 
prevalence of infection is measured day 7 pIBM. The experimental design from Figure 6 
is used.  
 
It was, however, unclear if this effect can be observed at lower concentrations of 
ATQ. Therefore, an ATQ dilution experiment was conducted, where female A. gambiae 
were fed 100µM ATQ + 0.5% DMSO, 10µM ATQ + 0.5% DMSO, and 1µM ATQ + 






























infectious blood meal. ATQ dilutions resulted in a dose-dependent inhibition of P. 
falciparum development in A. gambiae (Figure 8). The prevalence of infection decreased 
as the concentration of ATQ in the sugar meal increased. At 100µM ATQ, 10µM ATQ, 
and 1µM ATQ, the prevalence of infection for these exposure groups were 9.7%, 34.2%, 
and 59.3%, respectively (prevalence: two-sided Fisher’s Exact Test with Bonferroni 
correction, 100µM ATQ, n = 199, p < 0.0001; 10µM ATQ, n = 175, p < 0.0001; 1µM 
ATQ, n = 182, p = 0.1065). Despite this significant dose-dependent decrease in the 
prevalence of infection in the ATQ-exposed groups, there was no significant difference in 
the oocyst intensity between the control group and the ATQ-treated groups (intensity: 
Kruskal-Wallis test for multiple comparisons, 100µM ATQ, n = 199, p > 0.9999; 10µM 
ATQ, n = 175, p > 0.9999; 1µM ATQ, n = 182, p > 0.9999). The results from the pre-





Figure 8 Dilution series for ATQ sugar feeding assay. Results show the oocyst intensity 
and prevalence of infection of P. falciparum after A. gambiae females are exposed to 
100µM ATQ + 0.5% DMSO, 10µM ATQ + 0.5% DMSO, and 1µM + 0.5% DMSO, 
treated sugar (10% glucose solution) ad libitum for 24 hours right before an infectious 
blood meal. Oocyst intensity and prevalence of infection was measured day 7 pIBM. The 








































II. ATQ exposure via sugar feeding after an infectious blood meal showed 
significant inhibitory effects on the transmission of P. falciparum in A. gambiae. 
 
A mosquito continues sugar feeding after it takes a blood meal. Therefore, it was 
important to assess the effects of ATQ on post-infection parasite development. Females 
were starved for 24 hours before they were provided an NF54, P. falciparum blood meal, 
and 2 days pIBM, they were provided a continuous exposure to ATQ-treated sugar to 
determine whether ATQ-treated sugar feeding had an effect after a mosquito was infected 
(Figure 9). The oocyst intensity, prevalence, and oocyst size were measured on days 7, 
10, and 14 pIBM, and sporozoites were measured at day 14 pIBM. Based on these 
results, post-infection exposure to ATQ-treated sugars was carried out to determine the 






Figure 9 Post-infection sugar-feeding assay: Female A. gambiae mosquitoes were starved 
for 24 hours before given an infectious blood meal. Two days pIBM, A. gambiae females 
were given a continuous exposure of 100µM ATQ in 10% w/v glucose ad libitum. At 
days 7, 10, and 14, the prevalence and intensity of P. falciparum infection was measured. 
At day 14, the sporozoites per mosquito was counted.  
  
Female A. gambiae mosquitoes were infected with P. falciparum and then 
continuously exposed to 100µM ATQ + 0.05% DMSO in 10% glucose concentration ad 
libitum two days after the infectious blood meal (Figure 9). The oocyst intensity, 
prevalence of infection, and average oocyst size per mosquito were observed at 7, 10, and 
14 days after infection (Figure 10 and Figure 11). No significant differences were 
observed in oocyst intensity on any of the days (intensity: Kruskal-Wallis test for 
multiple comparisons; day 7, n = 100, p > 0.9999; day 10, n = 84, p = 0.3229; day 14, n = 
75, p > 0.9999, d7:d10 controls, n = 97, p > 0.9999, d10:d14 controls, n = 89, p > 0.9999, 
d7:d14 controls, n = 90, p > 0.9999). A significant inhibition of the prevalence of 
infection was instead observed between the control and ATQ-treated groups at day 7, 
while no difference was observed at day 10 nor at day 14 (prevalence: two-sided chi-
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squared test; day 7, n = 100, p = 0.0060; day 10, n = 84, p > 0.9999; day 14, n = 75, p = 
0.1100, d7:d10 controls, n = 97, p > 0.9999, d10:d14 controls, n = 89, p > 0.9999, d7:d14 
controls, n = 90, p > 0.9999).  
 
Figure 10 Results show the oocyst intensity and prevalence of infection of P. falciparum 
after A. gambiae mosquitoes were continuously exposed to 100µM ATQ + 0.5% DMSO-
treated sugar (10% glucose solution) ad libitum two days after their infectious blood 
meal. Oocyst intensity and prevalence of infection were collected on day 7, day 10, and 
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There was however a notable difference in the size of the oocysts, which 
suggested an inhibitory effect of ATQ on the development of P. falciparum in the 
mosquito midgut when fed ATQ-treated sugar continuously pIBM (Figure 11). At day 7, 
the mean of the average oocyst size per mosquito was 72 µm2 in the 100µM ATQ group 
as compared to374 µm2 in the control group. At day 10 and day 14, the average oocyst 
size per mosquito in the control and ATQ groups both increased in size; however, 
significant differences were still observed between the groups. At day 10, the mean of the 
average oocyst size per mosquito was 165 µm2 in the 100µM ATQ group, which was a 
significant decrease from the control group with mean of the average oocyst size per 
mosquito of 843 µm2. Day 14 increased to 337µm2 for the ATQ treated group while the 
control group was 1423µm2 mean of the average oocyst size per mosquito. (Intensity: 
unpaired T-test; day 7, n = 69, p < 0.0001; day 10, n = 70, p < 0.0001; day 14, n = 61, p < 
0.0001.) The size of the oocysts in the ATQ-treated group at day 14 suggested that the 




Figure 11 Results show the oocyst size of P. falciparum after A. gambiae mosquitoes 
were continuously exposed to 100µM ATQ + 0.5% DMSO-treated sugar (10% glucose 
solution) ad libitum two days after their infectious blood meal. Oocyst size were 
measured on day 7, day 10, and day 14 pIBM. The experimental design from Figure 9 is 
used.  
 
To confirm that the oocysts at day 14 after continuous ATQ-sugar exposure were 
not mature enough to produce sporozoites, the sporozoites were extracted from the 
salivary glands and counted. The ATQ-treated group had no sporozoites (Figure 12), 
while in the control group the median number of sporozoites per mosquito was 8,400 
(prevalence: two-sided Fisher’s Exact Test, n = 86, p < 0.0001). The complete inhibition 
of sporozoite development in ATQ-treated mosquitoes indicated that the mosquitoes were 
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Figure 12 Results show the number of P. falciparum sporozoites after A. gambiae 
mosquitoes were continuously exposed to 100µM ATQ + 0.5% DMSO-treated sugar 
(10% glucose solution) ad libitum two days after their infectious blood meal. The number 
of sporozoites are taken from the mosquito salivary glands on day 14 pIBM. The 







































III. HYD exposure through sugar feeding caused a dose-dependent decrease in the 
survival of A. gambiae females.  
 
It is known that HYD has insecticidal effects on other arthropods and is 
commonly used in ants and cockroaches (Decio et al., 2013). However, insecticidal 
effects of HYD has been tested against Anopheles and Aedes mosquitoes and was shown 
to have no effect by tarsal contact. Similarly to ATQ, HYD can also be used as a vector 
control tool and might have potential antimalarial effects through sugar feeding as it was 
seen to have through tarsal contact, Figure 5 (Paton et al., 2019). Females are starved for 
24 hours prior to exposure to HYD for 24 hours (Figure 13). Dead mosquitoes are 
counted and removed daily. This survival assay was carried out to see the effects of HYD 
on mosquito survival and to determine a suitable sub-lethal concentration of HYD to use 
for infection-inhibition experiments. 
 
Figure 13 HYD survival assay: A. gambiae females are starved for 24 hours before they 
are fed a HYD-treated sugar meal for 24 hours. The number of dead mosquitoes were 
counted and removed every 24 hours.  
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HYD at 100µM, 10µM, and 1µM were compared to three control groups—a 
standard control with 10% glucose solution and 0.5% DMSO, a water only control, and a 
control with nothing in the cage (Figure 14). Survival of the mosquitoes was measured by 
counting the number of dead mosquitoes every 24 hours after the removal of the 
exposures. At 100µM HYD, the mosquitoes had the most significant change in survival. 
By day 7 of the survival assay, all of the mosquitoes have died in the 100µM HYD 
exposure. As seen in Table 1, the risk ratio for 100µM HYD as compared to all the other 
treatments are all greater than 1, signifying that the mosquitoes given 100µM HYD had a 
higher risk of dying than the other groups (two-sided log-rank Mantel-Cox, 
100µM:Nothing, n = 80, RR = 3.51, p < 0.0001; 100µM:Water, n = 80, RR = 6.80, p < 
0.0001; 100µM:Sugar, n = 80, RR = 7.59, p < 0.0001; 100µM: 1µM, n = 80, RR = 8.00, 
p < 0.0001; 100µM: 10µM, n = 80, RR = 5.33, p < 0.0001). While the nothing control 
also had significant death at the beginning of the survival assay, there is statistically 
significant evidence that 100µM-HYD treated mosquitoes are 3.51 times more likely to 
die than mosquitoes given nothing. The 10µM HYD exposure had a milder decrease in 
survival, with the deaths plateauing at day 15 of the assay. Nonetheless, the risk of dying 
with a 10µM HYD exposure was not significantly greater than mosquitoes given a water 
control and a sugar control (two-sided log-ranked Mantel-Cox, 10µM:Water, n = 80, RR 
= 1.28, p = 0.2791; 10µM:Sugar, n = 80, RR = 1.42, p = 0.1163). When the mosquitoes 
were exposed to 1µM HYD, there was no significant decrease in survival as compared to 
the water and sugar controls (1µM: Water, n = 80, RR = 0.85, p = 0.4642; 1µM: Sugar, n 




Figure 14 A dilution series survival assay was performed by exposing A. gambiae 
females to a dilution of HYD (100µM, 10µM, and 1µM) + 0.5% DMSO in 10% glucose 
solution ad libitum for 24 hours. After 24 hours, 10% glucose solution without treatment, 
ad libitum, was given to the mosquitoes for the duration of the experiment. Dead 
mosquitoes were counted and removed every 24 hours. The experimental design from 




Treatment 1 Treatment 2 Risk Ratio1 P 
Nothing  HYD 100 µM 0.2852471 <.0001* 
Water  HYD 100 µM 0.1471669 <.0001* 
Sugar  HYD 100 µM 0.1317773 <.0001* 
HYD 1 µM  Water 0.8489229 0.4642 
HYD 1 µM Sugar 0.9480638 0.8115 
HYD 10 µM  Water 1.2751832 0.2791 
HYD 10 µM Sugar 1.4241045 0.1163 
HYD 100 µM  Nothing 3.5057323 <.0001* 
HYD 100 µM Water 6.7950082 <.0001* 
HYD 100 µM Sugar 7.5885581 <.0001* 
HYD 100 µM HYD 1 µM 8.0042698 <.0001* 
HYD 100 µM HYD 10 µM 5.3286526 <.0001* 
Table 1 The experimental design from Figure 13 is used. The survival of the two 
treatments are compared, and the risk ratio and significance are given in this graph. Risk 
ratio greater than 1 signifies that Treatment 1 has a greater likelihood to die by a multiple 






IV. HYD exposure through sugar feeding had a significant effect on the prevalence 
of P. falciparum infection.  
 
It was seen, through the survival assay, that 10µM decreased A. gambiae survival 
but the effect was not significant (Table 1). Therefore, 10µM HYD was used to observe 
the drug’s ability to work as an antimalarial. The mosquitoes were fed 10µM HYD + 
0.5% DMSO in 10% glucose ad libitum for 24 hours right before an infectious blood 
meal, and the oocysts were counted at day 7 post infection (Figure 6). At 10µM HYD, 
there was no significant effect of HYD on oocyst intensity, with the median oocysts per 
midgut at 7 for control group and 11 for the HYD-treated group. There was, however, a 
statistically significant inhibition of P. falciparum prevalence of infections in A. gambiae 
when treated with 10µM HYD (Figure 15). There was a 16.1% decrease in the 
prevalence of infection between the control group and the HYD-treated group 
(prevalence: two-sided Fisher’s Exact Test, n = 134, p = 0.0231; intensity: two-sided 




Figure 15 Prevalence of infection and oocyst intensity are shown. A. gambiae females 
were exposed to 10µM HYD + 0.5% DMSO in 10% glucose solution ad libitum for 24 
hours right before an infectious blood meal. The P. falciparum prevalence of infection 
and oocyst intensity were observed on day 7 pIBM. The experimental design from Figure 






























V. MET administered through tarsal contact did not affect P. falciparum infection in 
A. gambiae mosquitoes.   
 
Previous data has shown that MET, when topically applied on the thorax of A. 
gambiae mosquitoes, decreased the prevalence of P. falciparum infections (Childs et al., 
2016). It was unclear how effective MET was through tarsal contact, a more likely way 
for mosquitoes to take up compounds in field-like settings. Female A. gambiae 
mosquitoes were exposed to 1mmol MET coating a glass dish for an hour before an 
infectious blood meal, and the number of oocysts per midgut were measured 7 days post 
infection (Figure 16). Egg development 7 days pIBM was assessed as well (Figure18).  
 
 
Figure 16 Virgin female A. gambiae mosquitoes were exposed to 1 mmol/m2 MET for an 
hour right before being fed an infectious blood meal. Seven days pIBM, the prevalence 
and intensity of P. falciparum infection and egg development are assessed.  
 
Exposing virgin female A. gambiae mosquitoes to 1 mmol MET showed little to 
no significant effect on the prevalence and intensity of infection on mosquito midguts 
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taken on day 7 pIBM (Figure 17). While there is a decrease between the median of the 
control group and of the 1mmol MET group—31 oocysts per midgut and 17 oocysts per 
midgut, respectively— the decrease was not statistically significant. There is also an 
insignificant but visible increase in the oocyst intensity in the RME + MET group, where 
the median oocyst intensity is 42 compared to 34 in RME only. (prevalence: two-sided 
Fisher’s Exact Test with Bonferroni correction; control: MET, n = 94, p >  0.9999; RME: 
MET + RME, n = 102, p > 0.1374, control:RME, n = 95, p > 0.9999; intensity: Kruskal-
Wallis test with multiple comparisons; control:MET, n = 94, p = 0.9159, RME: 





Figure 17 Prevalence of infection and oocyst intensity are shown. A. gambiae females 
were exposed to a control, 1mmol MET, 100µmol RME, or 1mmol MET + 100µmol 
RME on a glass dish an hour right before an infectious blood meal. The P. falciparum 
prevalence of infection and oocyst intensity were observed on day 7 pIBM. The 































p = 0.9159 p > 0.9999
p > 0.9999 p = 0.1374
p = 0.7909
p > 0.9999
87.2% 85.1% 91.7% 100%
 
57 
VI. MET administered through tarsal contact had no effect on egg development in 
A. gambiae mosquitoes.  
 
Along with looking at oocyst intensity after 1 mmol MET exposure, egg 
development was also observed from this group of mosquitoes. As mentioned, MET is an 
insect growth regulator with known effects to decrease egg development in A. gambiae in 
a dose-dependent manner when topically applied on to the thorax (Childs et al., 2016). 
Virgin female A. gambiae mosquitoes were used because females typically cannot 
oviposit without mating. When exposing A. gambiae to MET through tarsal contact, there 
were no significant differences when comparing the egg development in the control to 
1mmol MET and in 100 µmol RME to 100 µmol RME + 1 mmol MET, as seen in Figure 
18 (intensity: ordinary one-way ANOVA with multiple comparisons; control:MET, n = 
105, p = 0.4061; RME:MET+RME, n = 102, p = 0.9709, control:RME, n = 99, p = 
0.9509). While there were no significant differences in the decrease between the control 
and MET exposure groups, there seemed to be a consistent but insignificant decrease in 
the number of eggs developed per mosquito in the MET group when compared to the 




Figure 18 Results show the number of eggs in each virgin female A. gambiae. Females 
were exposed to a control, 1mmol MET, 100µmol RME, or 1mmol MET + 100µmol 
RME on a glass dish 1-hour right before an infectious blood meal. The number of eggs 
per female was observed on day 7 pIBM. The experimental design from Figure 16 is 
used.  
 
This experiment was followed up with an oviposition assay where the same 
exposure groups were measured for the number of eggs laid and prevalence of egg laying 
amongst exposed, virgin female A. gambiae. After a 1-hour exposure, female mosquitoes 
are given a noninfectious blood meal. At 3 days pIBM, the number of eggs developed 
and laid were counted (Figure 19).  
 





























Figure 19 Virgin female A. gambiae females are exposed to MET for an hour before a 
non-infectious blood meal. Virgin females were used because female mosquitoes 
typically cannot oviposit without mating. Three days pBM, the prevalence of oviposition, 
number of eggs laid per female, and number of eggs per mosquito is counted.  
 
Under normal circumstances, females must be mated and take a blood meal in 
order to lay eggs; however, it has been shown that MET can induce egg laying in blood 
fed virgin female mosquitoes when administered through topical application on the 
thorax (Childs et al., 2016). In the oviposition assay (Figure 20), there were no significant 
differences between the control groups and the MET exposure groups in terms of the 
number of eggs laid nor in terms of the prevalence of virgin females that laid their eggs 
(intensity: ordinary one-way ANOVA with multiple comparisons; control:MET, n = 126, 
p = 0.9947; RME:MET+RME, n = 137, p = 0.9787, control:RME, n = 130, p = 0.8930; 
prevalence: two-sided Fisher’s Exact Test with Bonferroni corrections; control:MET, n = 






Figure 20 The number of eggs laid per virgin female A. gambiae and the prevalence of 
females that laid their eggs is shown above. Female A. gambiae mosquitoes were exposed 
to a control, 1mmol MET, 100µmol RME, or 1mmol MET + 100µmol RME on a glass 
dish 1-hour right before a regular, non-infectious blood meal, and eggs were counted 3 
days after the blood meal. The experimental design from Figure 19 is used.  
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VII. MET administered through sugar feeding significantly decreased egg 
development in virgin female A. gambiae.  
 
To establish a more effective method of administering MET, mosquitoes were 
starved for 24 hours and then fed a 10% glucose solution mixed with a 100 µM MET and 
0.5% DMSO solution for 24 hours before their noninfectious blood meal (Figure 19). As 
expected, there was a significant decrease, as seen in Figure 21, in the number of eggs 
developed in each virgin female mosquito, where a mean of 125 eggs per female was 
observed in the controls and a mean of 107 eggs per female was observed in the treated 
(intensity: unpaired t-test, n = 165, p = 0.0010). This data supported the results from a 
previous MET study that MET decreased the egg development in female mosquitoes 





Figure 21 The number of eggs developed per virgin female A. gambiae is shown above. 
Females were exposed to 100µM MET + 0.5% DMSO in 10% glucose solution ad 
libitum for 24 hours right before a non-infectious blood meal. Egg development is 




























VIII. MET administered through tarsal contact showed no significant effects on 20E 
levels 24 hours after a blood meal.  
 
In order to understand how MET is affecting 20E signaling in female mosquitoes, 
a 20E enzyme immunoassay (EIA) was used to detect 20E levels. Females were exposed 
to 100µmol RME only and 100µmol RME + 1 mmol MET at 24 hours before a blood 
meal and at 0 hours before a blood meal for 1 hour via tarsal contact (Figure 22). The 




Figure 22 Virgin female A. gambiae mosquitoes were exposed to 1mmol/m2 MET 
through tarsal contact for an hour either right before a non-infectious blood meal or 24 
hours before a non-infectious blood meal. Twenty-four hours after the blood meal, blood-
fed females were beheaded and stored in methanol, in preparation for an ELISA to detect 




When the virgin female mosquitoes were exposed 24 hours before a blood meal, 
there was no significant difference in 20E levels between the control, RME only, group 
and the exposure, RME plus MET, group. When the virgin female mosquitoes were 
exposed 0 hours before a blood meal, there was no statistically significant difference in 
20E levels between the control and treated groups (Figure 23). However, there is a 
noticeable but insignificant decrease in the RME+MET groups in both the 24 hours 
before blood feed and 0 hours before blood feed groups (20E detection intensity: one-
way ordinary ANOVA with multiple comparisons; 0 hours, n = 36, p = 0.4035; 24 hours, 




Figure 23 An ELISA was performed to detect the levels of 20E in A. gambiae females 
exposed to 1mmol MET + 100µmol RME or 100µmol RME only either 0 hours before a 
blood meal or 24 hours before a blood meal. 20E levels are measured at 24 hours after the 
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P. falciparum development has been successfully arrested by exposing 
A. gambiae females to ATQ-treated sugar meals either before or after an infectious blood 
meal. Paton, et al., previously established that there was a dose-dependent effect of ATQ 
exposure on the prevalence and intensity of P. falciparum infections when ATQ was 
administered before an infectious blood meal through tarsal contact. There was an 
observed arrest of parasite development at the zygote stage, so oocysts did not develop 
(Paton et al., 2019). The pre-infection sugar feeding assays, as seen in Figure 8, also 
showed a dose-dependent decrease in the prevalence of P. falciparum infection, but this 
dose-dependent effect was not reflected in the oocyst intensity. While these results 
indicate that pre-infection ATQ-treated sugar feeding can successfully arrest parasite 
development, further research must be done to determine the stage at which pre-infection 
ATQ-treated sugar feeding blocks parasite development. An immunofluorescent assay 
using the parasite-specific antibody, anti-Pfs25, can be done 18-24 hours after a P. 
falciparum blood meal on the midgut lumen, where the bloodmeal is held. The time 18-
24 hours after a blood meal is consistent with when ookinetes should have already 
formed, as seen above in Figure 3. Pfs25 surface proteins are found on developing 
zygotes and ookinetes in the midgut lumen (Barr et al., 1991; Vermeulen et al., 1985). It 
is hypothesized that, like the pre-infection ATQ-treated tarsal contact exposures, pre-
infection ATQ-treated sugar feeding will also block parasite development predominantly 
at the zygote stage. Determining the stage at which pre-infection ATQ-treated sugar 
feeding halts P. falciparum infections in A. gambiae can help develop a better picture of 
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the similarities and differences between pre-infection sugar feeding and pre-infection 
tarsal contact exposures. Despite having no effect on oocyst intensity, the use of ATQ-
treated sugar meals can greatly reduce prevalence of malaria infections in mosquito 
populations. The inability for parasites to survive at 100µM ATQ can decrease vector 
capacity, leading to decreased transmission of malaria to humans.  
As seen in Figure 7, it is clear that 100µM ATQ can completely suppress oocyst 
development in the midgut; however, as seen in Figure 8, complete suppression does not 
always occur across multiple replicates. It is likely that the 10 infected mosquitoes in the 
100µM ATQ-treated group were individual mosquitoes that did not imbibe the ATQ-
treated sugar meals or did not imbibe as much sugar. This could be due to environmental 
differences that provided mosquitoes with enough moisture to forgo drinking treated 
sugars or due to individual differences where some did not need to imbibe sugar as often 
for energy metabolism. Further research must be conducted to determine whether the 
incomplete suppression is a behavioral effect, where some mosquitoes are not feeding on 
the ATQ-treated sugar, or some form of metabolic or target-site resistance against ATQ. 
To determine if this is a feeding behavior effect, the 10% glucose solutions can be mixed 
with food dye. Dyed sugar can be observed, by eye, in the mosquito crop, as mosquitoes 
are somewhat translucent. If all the mosquitoes feed on the ATQ-treated sugar during a 
24-hour period across multiple replicates, then it can be assumed that factors other than 
behavior, such as ATQ resistance, are at play. If some of the mosquitoes do not feed on 
the ATQ-treated sugar during a 24-hour period across multiple replicates, it can be said 
that sugar feeding behavior plays a role in the incomplete suppression of oocyst 
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development. However, to confirm that the behavioral effects are not mixed with effects 
of ATQ resistance, A. gambiae females that did not feed on the sugar meal, as seen 
through the presence of dye, should be removed prior to an infectious blood meal. 
Repellency to ATQ-treated sugar meals in lab settings would only be exaggerated in field 
settings, where mosquitoes have access to other sources of sugar meals. While attractants 
were not added into ATQ-treated sugar meals in the experiment, it is important to 
replicate this experiment in field-like settings with attractants and other sources of sugar 
meals to determine if mosquitoes will choose ATQ-treated ATSBs over other options. 
ATQ, nonetheless, has strong evidence of success in reducing malaria transmission and 
should be added into the developing arsenal of malaria control tools.  
The pre-infection ATQ-treated sugar feeding dilution series assay produces an all-
or-nothing response in prevalence of infection and oocyst intensity, as seen in Figure 8. 
While there were significant decreases in the prevalence of infection when given 
increasing concentrations of ATQ-treated sugar meals, this observation did not carry 
through to the oocyst intensity, where the number of oocysts per midgut showed no 
significant changes across the different groups, including the control group. Suppression 
was occurring in a dose-dependent manner, but in mosquitoes where complete 
suppression did not occur, there was no effect on P. falciparum infection. Despite 
explaining the incomplete suppression at 100µM ATQ with potentially non-feeding 
mosquitoes, the increasing prevalence of infection in the 10µM and 1µM ATQ treatment 
groups should be due to the decreasing concentration of ATQ rather than to repellency to 
ATQ-treated sugar meals. It is unlikely that more mosquitoes were repelled from feeding 
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on lower concentrations of ATQ. To rule out behavioral repellency to ATQ-treated sugar 
meals, an ATQ dilution series with dye mixed into 10% w/v glucose solution should be 
conducted. If A. gambiae females were repelled from taking an ATQ-treated sugar meal, 
they would likely be most deterred from sugar meals with the highest concentration, 
100µM ATQ. Under the assumption that, at 100µM, all of the infected mosquitoes were 
ones that didn’t feed on the ATQ-treated sugar meal, the repellency of sugar feeding in 
individual A. gambiae females could be obscuring a significant dose-dependent effect on 
oocyst intensity at 10µM and 1µM ATQ. The expectation to see a decrease in oocyst 
intensity with increasing ATQ concentration is due to a similar experiment done using 
tarsal contact, as previously mentioned. However, this experiment was done with a 6-
minute exposure right before an infectious blood meal and through tarsal contact 
exposure, so the two experiments cannot be directly compared. One just serves as an 
example of dose-dependent effects from a dilution series assay. It is, nonetheless, logical 
to assume that oocyst intensity should be affected before the prevalence of infection is 
affected, given that a decrease in oocyst intensity is seemingly a milder effect than a 
decrease in the prevalence of infection.  
The distinct effects on oocyst intensity could also result from differences in ATQ 
exposure through tarsal contact versus through sugar feeding. In sugar feeding, the ATQ-
treated sugar meals, like most glucose-based sugar meals, will enter into the crop, a 
second stomach that stores the sugar and releases it over time into the midgut. The highly 
lipophilic ATQ could potentially be transported to the midgut in two ways: 1) pumped 
into the midgut with the sugar meal, or 2) diffused through the crop wall into the 
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hemolymph and eventually into the midgut. Through tarsal contact, ATQ potentially 
penetrates the cuticles and circulates in the hemolymph, where it will diffuse into the 
midgut lumen. In sugar feeding experiments, the wide range of exposure (24 hours) 
makes it difficult to track precisely when A. gambiae females are taking sugar meals. The 
difference in metabolism in an A. gambiae female taking her ATQ-treated sugar meal at 
the beginning of the 24-hour exposure versus at the middle or end of the 24-hour 
exposure is unclear. This can be clarified by shortening the exposure time. Another 
consideration is how the sugar meal is affected by the blood meal and vice versa. Since 
the mosquitoes take a blood meal right after the 24-hour exposure, it is unclear how much 
of the sugar meal taken before the blood meal will be digested, and thus, it is unknown 
whether the ATQ effects stem from ATQ circulating in the hemolymph, ATQ entering 
the midgut with the sugar meal, or both. Nonetheless, ATQ, through sugar feeding, was 
able to circumvent tarsal contact, which is heavily affected by cuticular resistance in the 
field. 
Previous experiments showed that a 6-minute tarsal contact exposure, 24 hours 
before a blood meal, completely suppressed the development of oocysts. The same results 
were seen with a 6-minute tarsal contact exposure right before a blood meal (Paton et al., 
2019). This shows that ATQ, through tarsal contact, was still active after 24 hours in the 
mosquito and was not fully metabolized during that time. It also showed that ATQ, 
through tarsal contact, has a fast mode of action, being able to inhibit early mosquito-
stage parasite development when given immediately before an infectious blood meal. 
These results suggest that ATQ circulation in the hemolymph is sufficient in blocking 
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malaria transmission if it were administered any time between 0-24 hours before an 
infectious blood meal. If ATQ circulation in the hemolymph is the mechanism for tarsal 
contact assays, it leads to question whether potential ATQ diffusion into the hemolymph 
during sugar feeding is sufficient for arresting parasite development and, if so, what 
effects ATQ propelled into the midgut with a sugar meal has on the mosquito and 
parasite development. Further research must be done to understand the pathway ATQ 
takes to reach the parasites in the midgut and if timing of the meal has an effect on oocyst 
intensity and prevalence of infection as well. This could include extracting the 
hemolymph and midgut and determining the concentration of ATQ found in each 
compartment at different time points before and after a blood meal. Moreover, a better 
way to parse out the different effects of tarsal contact and sugar feeding on oocyst 
prevalence and intensity is to run the infection experiments side-by-side, as the lack of a 
dose-dependent change in oocyst intensity could be specific to the infections rather than 
to the treatments.  
The transmission of P. falciparum is stopped when A. gambiae females are 
exposed to continuous post-infection ATQ-treated sugar meals. The median oocyst 
intensities per midgut in the treated groups at day 7, day 10, and day 14, were noticeably 
lower than the median oocyst intensities per midgut in the associated controls, but they 
were not significant. Only on day 7 is the prevalence of infection of the ATQ-treated 
group significantly lower than that of its control. Since the mosquitoes at day 7, 10, and 
14, all belong to the same group of mosquitoes, they should have a similar prevalence of 
infection and oocyst intensities. Oocyst development is dependent on the number of 
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ookinetes that penetrate the midgut epithelium 2 days pIBM. Therefore, there were no 
expectations of an increase in the prevalence of infection between day 7 and day 10/14. 
By the time ATQ-treated sugar meals are provided, the ookinetes should have already 
encysted into the midgut epithelium. It is possible that at day 7, the oocysts are too small 
to visualize, even at 400x on a compound inverted microscope. Experiments with higher 
powers for detection should be used. Immunofluorescent microscopy, where the oocysts 
can be visualized by anti-Pfs25-fluorescent conjugated antibodies, will provide greater 
labelling contrast than mercurochrome. Nonetheless, the significantly smaller oocysts 
show that ATQ has a fast mode of action and is effective soon after administration. There 
was an increase in the mean size of the oocysts per mosquito midgut despite being fed 
continuous ATQ-treated sugars from 2 days pIBM. In the post-infection exposures, ATQ 
merely slows down the parasite growth rather than stops it. Pre-infection ATQ exposures, 
with both sugar feeding and tarsal contact, arrest parasite growth. This indicates that 
parasite development before midgut invasion and parasite development after midgut 
invasion do not rely on the same mechanisms or pathways, and parasite development 
after midgut invasion does not rely as heavily on cytochrome bc1 function. 
 The function of ATQ is to inhibit cytochrome bc1 in the inner mitochondrial 
membrane. This prevents ATP production and de novo pyrimidine synthesis. In both the 
formation of zygotes and the formation of sporozoites, DNA replication, and thus de 
novo pyrimidine synthesis, is an important process of development. However, it is 
unclear whether ATP synthesis or DNA replication plays a bigger role in establishing P. 
falciparum infections in A. gambiae females. This can be studied by using transgenic P. 
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falciparum parasites that are able to perform de novo pyrimidine synthesis without the 
cytochrome bc1 complex by inserting a cytoplasmic dihydroorotate dehydrogenase 
(DHOD) enzyme, an experiment previously studied by Painter, et al., to determine the 
necessity of de novo pyrimidine synthesis in blood-stage malaria parasites (Painter et al., 
2007). DHOD is an essential protein for the de novo pyrimidine synthesis pathway and 
functions via an oxidation-reduction relationship with cytochrome bc1. ATQ will inhibit 
the mitochondrial DHOD, thus de novo pyrimidine synthesis, and ATP synthesis, but de 
novo pyrimidine synthesis will be rescued by the cytoplasmic DHOD. If normal parasite 
development in these transgenic parasites does not occur with ATQ exposure, then it is 
clear there is a greater reliance on ATP than on de novo synthesis. By administering 
ATQ-treated sugar before or after an infectious blood meal while using transgenic 
cytoplasmic DHOD parasites, it is possible to determine the important mechanisms of 
cytochrome bc1 at each point of parasite development. The ATQ-treated feeding assays 
show that ATQ has stronger effects when administered before an infectious blood meal 
than after an infectious blood meal. It is hypothesized that parasite development before 
midgut invasion relies more heavily on the functions of cytochrome bc1 than parasite 
development after midgut invasion. Further research must be done to understand the 
mechanism of ATQ’s role on parasite development before and after P. falciparum 
invades the midgut epithelium. Understanding ATQ’s role in sugar-feeding before and 
after malaria transmission to the mosquito can improve the understanding of vector 
control tools and how and when to apply them.  
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The significantly smaller size of the oocysts in the ATQ-treated groups suggests 
that the oocysts development, though not arrested, had not developed into mature oocysts 
to produce sporozoites by day 14, which is supported when looking at day 14 sporozoite 
counts. There is complete inhibition of P. falciparum infectivity at day 14 by ATQ-
treated sugars pIBM. Given more time and the removal of the ATQ-treated sugars, there 
is a chance that oocysts make a fully recovery and become infectious. However, the 
observation that ATQ slows down the maturation and development of P. falciparum is 
impressive and points towards significant progress because of the way it will impact the 
vectoral capacity of A. gambiae females by decreasing the vector competence. Even if the 
oocysts were able to mature and to eventually develop sporozoites, the probability that 
the infected female mosquito is still alive decreases. Especially if ATQ is used in ATSBs, 
where toxic compounds could be included in the sugar to shorten the lifespan of 
mosquitoes, the prolonged pathogen incubation period and decreased survivability from 
the toxic component of ATSBs could greatly reduce the mosquito’s capacity to transmit 
malaria.  
 HYD has significant insecticidal effects on adult A. gambiae females, leading to 
greater decreases of survival with 100µM HYD. The three controls were selected to 
determine whether the extreme 100µM HYD effects were due to repellency to a toxic 
sugar meal, leading to starvation and death, or due to the insecticide itself. The “nothing” 
control imitated the repellency effect, and mosquitoes in the “nothing” control group 
were deprived of sugar and water during the 24 hours exposure period. Despite similar 
survival trends earlier in the experiment, there was statistically significant evidence that 
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mosquitoes exposed to 100µM HYD through sugar feeding had a greater risk of dying. 
The difference between the “nothing” control and 100µM HYD survival was obvious 
when survival in the “nothing” control group plateaued while the survival in the 100µM 
HYD group plummeted; none survived after day 7 of the survival assay. While A. 
gambiae females in the “nothing” control group did not survive well, the decrease in 
survival was rescued after they were given un-treated sugar and water. The effects of 
100µM HYD is not due to repellency. HYD would be a great asset in the arsenal of 
insecticides to use in ATSBs since it is toxic against adult A. gambiae females. 
Nonetheless, mosquito preference isn’t taken into account in the survival assays, so it is 
unclear whether a mosquito would prefer attractive sugar baits with HYD inside when 
they have other sugar source choices. A similar case could be made when assessing the 
effectiveness of ATQ in sugar baits, as we don’t know if there will be a preference for 
other sources of sugar meals. In order to better understand how mosquitoes interact with 
ATSBs in the field, it is important to carry out these studies in field-like settings before 
implementing them worldwide. A better knowledge of the efficacy of ATQ and HYD in 
ATSBs can also help eliminate the possibility of developing resistance against these 
compounds. Since HYD has different molecular targets from previously used 
insecticides, HYD can also contribute to increasing variation in multiple-insecticide 
formulas.  
HYD was selected due to its already seen effects on reducing the prevalence of P. 
falciparum infection through tarsal contact (Paton et al., 2019). Using sugar feeding to 
test the effects of HYD on P. falciparum infection, however, proved to be difficult since 
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the mosquitoes died before oocysts could be counted at day 7 pIBM. Through the 
survival assay, it was determined that 10µM HYD should be used due to its incomplete 
insecticidal effect on A. gambiae females after a 24-hour exposure. In the sugar feeding 
assay, it is seen that HYD can significantly decrease the prevalence of P. falciparum 
infection in A. gambiae but has no effect on the oocyst intensity. Once again, an all-or-
nothing effect is seen through the prevalence of infection and the intensity of infection. 
This is consistent with previous data (see above, Figure 5) that observed similar effects of 
1mmol/m2 HYD exposure on P. falciparum development in A. gambiae through tarsal 
contact: HYD had a significant effect on the prevalence of infection but none on the 
oocyst intensity. From a previous study, HYD is seen to have a 100-fold higher EC50 
compared to ATQ in asexual P. falciparum parasites (Witschel et al., 2012). This could 
explain the reduced efficacy of the drug, seeing as 10µM of HYD significantly decreases 
the prevalence of infection from 89.9% in control groups to 73.8% in treated groups, 
while 10µM of ATQ decreases the prevalence of infection from 74% in control groups to 
34.2% in treated groups. The same experimental design was used.  
As seen from the survival assay, the greatest decrease in survival at 10µM HYD 
doesn’t occur until 9-10 days after the exposure. It is likely that HYD, at lower 
concentrations, has a delayed effect on the survival of mosquitoes, and the longer the 
mosquitoes survived, the more the HYD is metabolized and cleared from the mosquito 
body, hence the plateauing mosquito survival. The delayed effects and eventual clearance 
of HYD could also explain why there were no changes in the oocyst intensity. The 
decrease in prevalence could be due to mosquitoes with slower metabolism. The 
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mosquitoes with no infections could be mosquitoes that could not fully metabolize HYD 
and will eventually die from HYD. Since the infection experiment cut off on day 7, the 
effects of HYD on the oocysts, infection, and mosquito survival might not have been 
fully visible. It will be interesting to see if there is any effect on oocyst size with HYD 
treatment or prolong the study to see if there is any effect on the parasite’s ability to 
develop transmissible sporozoites. Additionally, removing mosquitoes at earlier time 
points—before some mosquitoes die from HYD toxicity—and looking at the oocyst 
intensity and prevalence of infection could also improve understanding of HYD’s effects 
during malaria infection in mosquitoes. In terms of malaria control, a delayed 
antimalarial effect could be beneficial when combined with ATQ’s fast-acting 
antimalarial effect by substantially decreasing malaria transmission even after multiple 
infectious blood meals. Further research must be done, however, to determine whether 
HYD does have a delayed antimalarial effect when administered through sugar feeding.  
MET, an insect growth regulator, is an agonist of 20E, an important ecdysteroid 
hormone involved in many aspects of an insect life cycle, such as in molting, mating, and 
egg development. Previous research on the effects of MET on adult A. gambiae females 
was done by topically applying MET on their thoraxes (Childs et al., 2016). However, 
this is not applicable for the field, as current popular malaria and vector control tools, 
such as IRS and LLINs, typically target tarsal uptake. Thus, MET was administered 
through tarsal uptake to determine if the its effects through topical application on the 
thorax could be replicated. There were no significant changes in oocyst intensity, in 
prevalence of infection, nor in egg development and eggs laid when comparing 
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1mmol/m2 MET to the control. This could suggest that through tarsal contact, insufficient 
concentrations of MET enter the mosquitoes. The results suggest that MET through tarsal 
uptake is not an efficient method of administering MET, even with the addition of RME 
that was shown to enhance the bioavailability of several insecticides. There were also no 
significant differences in 20E concentration levels when mosquitoes were exposed to 
RME+MET 0 hours before the blood meal and 24 hours before the blood meal. Childs, et 
al. showed that MET caused significant changes in egg development, ovipositioning, and 
Plasmodium infections when topically applied to the A. gambiae thorax (Childs et al., 
2016). MET that is applied topically onto the thorax tends to have better absorbance 
because the acetone mixed into the compound dissolves bits of the cuticle to dissolve 
larger amounts of MET into the mosquito. On the other hand, tarsal contact plates only 
have 1 mmol per m2 of MET, and there is no way to visually the uptake of the compound.  
There was, however, a significant decrease in the number of eggs developed per 
female after A. gambiae females were fed MET-treated sugar meals. This suggests that 
sugar feeding could be an effective way of delivering MET. However, Werling et al., 
showed that disrupting 20E signaling by knocking down EcR resulted in decreased egg 
development per mosquito and decreased oocyst intensity. A decrease in oocyst intensity 
per midgut might not always be a sign of decreased transmission. It has shown that a 
decreased oocyst intensity per midgut often led to an increased oocyst size and thus faster 
sporozoite development and transmission of malaria (Werling et al., 2019). MET’s 
disruption of 20E signaling is by binding to EcR, which does not have the same effect as 
knocking down EcR, but similarly, there was a decrease in the number of eggs developed 
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per mosquito. Further research needs to be done to assess MET-treated sugar feeding has 
an effect on the prevalence or intensity of infection and on the oocyst size or parasite 
transmission. Caution must be taken when disrupting the 20E signaling pathway, as a 
decrease in egg development and in parasite intensity could lead to faster transmission.  
When comparing the three compounds and their potential as vector control 
compounds, it is clear that ATQ is exceptionally suited for vector control. In cases of 
tarsal contact and sugar feeding, ATQ was able to significantly halt the transmission of 
malaria parasites and does not have known toxic effects against the mosquito itself. HYD 
works relatively well in terms of decreasing the prevalence of infection in A. gambiae 
females and works extremely well as an insecticide, to decrease the survival of A. 
gambiae females after a 24-hour exposure to the 10% glucose solution ad libitum. 
Nonetheless, its efficacy in sugar baits has yet to be tested. Previous studies on HYD in 
ant baits suggest that HYD might be photolabile, which might impact the stability of 
HYD in field-like conditions (Hooper‐Bùi & Rust, 2001; Van der Meer et al., 1982). 
MET through tarsal contact has shown no significant effects on infection nor on egg 
development. However, a significant decrease in the number of eggs developed after 
exposure to MET-treated sugar meals was observed. However, as a warning from the 
Werling et al.’s 2019 study, disrupting reproductive pathways in A. gambiae might not be 
the best solution for eliminating malaria transmission (Werling et al., 2019).  
A. gambiae female adults will typically have their first blood meal at day 5 after 
they have become adults. As female mosquitoes grow older, the likelihood of carrying P. 
falciparum increases. A. gambiae tend to feed indoors at dusk, and they will likely rest 
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indoor as well. Many of the current malaria control tools target this indoor feeding and 
resting behavior. However, not all Anopheline mosquitoes that carry Plasmodium dwell 
indoors, with some mosquitoes adapting their behaviors to circumvent the increasing 
number of insecticides inside homes (Ranson et al., 2011). The significant impact that 
HYD and, in particular, ATQ has on the prevalence of infection through sugar feeding 
can be used to target those mosquitoes that feed outdoors or are shifting their behaviors 
biting and resting behaviors. Even without behavioral resistance, mosquitoes that feed 
and rest indoors must travel out to find sugar meals, so using sugar baits as a vector and 
malarial control tool broadens the range of mosquitoes that can be targeted (Qualls et al., 
2015). Nonetheless, more research needs to be done on the sugar feeding behavior of 
mosquitoes to improve the use of ATSBs for malaria and vector control and to decrease 
the chances of resistance building against these compounds.  
 
Future Directions 
 Despite the significant effects of ATQ on the development of P. falciparum in A. 
gambiae, it is important to fully understand the limitations of ATQ before using it for 
malarial control. With the oocysts increasing in size despite continuous exposure to ATQ, 
it is important to assess whether the oocysts will eventually mature and develop 
sporozoites despite the continuous ATQ exposure. This can be done by extending the 
study until 21 or more days. Furthermore, it is also important to see the effects on oocyst 
size and sporozoite transmission when the continuous ATQ is taken away after a few 
days of feeding. This can be done by removing ATQ-treated sugar exposures and by 
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replacing them with regular 10% glucose solutions to see if the infection can be rescued 
by eliminating ATQ. Since there is potential for ATQ-use in ATSBs, exploring the type 
of toxic compounds, such as HYD, and attractants that ATQ could be mixed with in 
ATSBs can contribute greatly to malaria control tool development. Historically, malaria 
control failed due to the lack of combination therapies and vector control tools that 
targeted multiple points in a pathway or organism. It is important that moving forward, 
caution is taken to ensure resistance does not build against the tools we are currently 
developing. It is important to be careful to fully understand the effects of a compound on 
malaria transmission before placing them in control tools .  
To support malaria control tool development, there needs to be more antimalarial 
and insecticidal compounds that will work on LLINs and in ATSBs as well. The current 
arsenal of useable compounds is diminishing, with greater insecticide and antimalarial 
resistance, so more compounds are needed to replace those that no longer work as 
effectively. On a more molecular level, it will be interesting to understand how much 
ATQ is actually circulating through the hemolymph of the mosquito after a blood meal or 
through tarsal contact. This can also explain how other such compounds circulate through 
the mosquito body when fed through sugar meals. By quantifying the amount of ATQ 
that is actually in the mosquito, it will open doors to creating more effective tools against 
P. falciparum. Knowing the quantity of ATQ within the mosquito needed to effectively 
stop transmission is important to formulate more precise concentrations of treated-sugar 
baits or LLINs. Additionally, knowing the concentration of compounds in mosquitoes 
after various methods of intake can help researchers make better decisions on which kind 
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of compounds to use in which kind of tools. Further studies must still be done to assess 
mosquito sugar preferences, as ATSBs and other forms of sugar baits would generally be 
ineffective if mosquitoes are choosing to other sources of sugar than the treated ones. As 
all of the experiments conducted were done in laboratory settings, it is important to test 
these forms of malaria control in actual field-like settings, where the tools most similar to 






There are lessons to be learned from our previous failures in malaria control. 
Monotherapies of antimalarials and insecticides have led to developing resistance in both 
Anopheles mosquitoes and Plasmodium parasites. While these experiments assess only 
the effects of single compounds on malaria transmission, it is important to be cautious in 
the use of one single compound in field settings. History has already shown, through 
GMEP and after the discovery of artemisinin, that using a single insecticide or 
antimalarial as a panacea for malaria spells trouble for the future generations and builds 
resistance against the drug. This research is to supplement tool development, and the 
compounds tested should be used in combination with other compounds that exerts its 
function on other targets in the organism. The research shines light on the great potential 
ATQ has in the future of malaria control and also discusses two other compounds—
HYD, which wasn’t previously used against mosquitoes, and MET—that could 













Treatment 1 Treatment 2 Risk Ratio1 P Lower 95% CI Upper 95% CI 
Nothing Water 1.9382564 0.0034* 1.2490912 3.007657 
Nothing Sugar 2.1646143 0.0007* 1.3947641 3.3593888 
Nothing HYD 1 µM 2.2831948 0.0003* 1.4711198 3.5435446 
Nothing HYD 10 µM 1.5199827 0.0636 0.9780479 2.3622027 
Nothing HYD 100 µM 0.2852471 <.0001* 0.1700874 0.478377 
Water Nothing 0.5159276 0.0034* 0.3324847 0.800582 
Water Sugar 1.1167843 0.6215 0.7204694 1.7311034 
Water HYD 1 µM 1.1779632 0.4642 0.7598938 1.8260412 










Water HYD 100 µM 0.1471669 <.0001* 0.0869789 0.249004 
Sugar Nothing 0.4619761 0.0007* 0.2976732 0.7169671 
Sugar Water 0.8954281 0.6215 0.5776662 1.387984 
Sugar HYD 1 µM 1.0547814 0.8115 0.6804746 1.6349821 
Sugar HYD 10 µM 0.7021957 0.1163 0.4522196 1.0903524 
Sugar HYD 100 µM 0.1317773 <.0001* 0.0776935 0.2235099 
HYD 1 µM Nothing 0.4379828 0.0003* 0.2822033 0.6797543 
HYD 1 µM Water 0.8489229 0.4642 0.5476328 1.3159734 
HYD 1 µM Sugar 0.9480638 0.8115 0.6116275 1.4695626 
HYD 1 µM HYD 10 µM 0.6657263 0.071 0.4286505 1.0339227 













HYD 10 µM Nothing 0.6579022 0.0636 0.4233337 1.0224448 
HYD 10 µM Water 1.2751832 0.2791 0.8215615 1.97927 
HYD 10 µM Sugar 1.4241045 0.1163 0.9171347 2.2113149 
HYD 10 µM HYD 1 µM 1.5021189 0.071 0.9671903 2.332903 
HYD 10 µM HYD 100 µM 0.1876647 <.0001* 0.1121542 0.3140145 
HYD 100 µM Nothing 3.5057323 <.0001* 2.0904016 5.8793292 
HYD 100 µM Water 6.7950082 <.0001* 4.0159997 11.497047 
HYD 100 µM Sugar 7.5885581 <.0001* 4.474075 12.871088 
HYD 100 µM HYD 1 µM 8.0042698 <.0001* 4.7119818 13.596898 
HYD 100 µM HYD 10 µM 5.3286526 <.0001* 3.1845664 8.9162966 
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